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Abstract 
Hematopoietic stem cells (HSCs) are responsible for the continuous production of all blood cells. 
This unique ability has made it possible to successfully use HSCs in the clinical setting to remedy 
various blood disorders. However, despite six decades of research, the full potential of HSCs to treat 
patients with hematological malignancies is still restricted by the low number of functional stem 
cells that can be isolated from different sources. In vitro HSC expansion has been widely considered 
a potential solution but has proven to be extremely difficult due to the rapid loss of functional po-
tential of cells in the culture outside of their natural microenvironmental niche. In order to achieve 
robust HSC expansion in vitro, it is crucial to better understand the mechanisms that regulate HSC 
fate choices. Moreover, the absence of reliable markers for identifying functional HSCs on a culture 
dish necessitates the use of expensive and time-consuming in vivo assays. The discovery of predic-
tive phenotypic markers for HSC potential could address this problem. Many platforms for analyzing 
HSC fate at the single-cell level have been reported, but they generally suffer from poor cell viability, 
limited throughput, unreliable phenotyping by immunocytochemistry, and the difficulty of perform-
ing long-term cell cultures. Additionally, these platforms are usually fabricated from polydime-
thylsiloxane (PDMS), a polymer known to have several disadvantages for cell-based applications. 
This thesis addresses these shortcomings through the development of a robust microchip system 
for the high-resolution, live-cell analysis of hundreds to thousands of single stem cells and their 
daughter cells. The platform combines key advantages of microfluidic technology (for cell lineage 
analysis) and hydrogel microwell array technology (for gentle cell capture and long-term culture). 
The platform is fabricated from two different layers of hydrogel to create a closed array of grooves, 
where cells’ movements are restricted and grow along one axis. This design enables an unambigu-
ous tracking of a single cell and all of its progeny over several generations. These two layers are 
produced from different biocompatible hydrogels: poly (2-hydroxyethyl methylacrylate) / trime-
thylolpropane trimethacrylate (pHEMA-TMPTMA), a copolymer acting as a topographically struc-
tured cellular substrate that can be closed with a polyethylene glycol (PEG) hydrogel lid. These two 
parts are combined together and covalently bonded to each other after the seeding of live cells into 
the grooves of the bottom part. To assess the potential of the platform for single stem-cell analyses, 
HSCs were cultured and their behavior (including cell fate, proliferation kinetics, and functionality) 
were thoroughly characterized. 
To analyze imaging data obtained from single-cell time-lapse experiments performed on the plat-
form, an algorithm was developed to automatically identify and track single HSCs and their daughter 
cells, efficiently extracting various parameters, such as single-cell proliferation kinetics, cell fate 
choices, and lineage relationships.  
Mitochondria have recently been identified as key modulators of HSC function; however, their spe-
cific role in fate regulation has remained obscure. Therefore, the single-cell analysis platform was 
applied to measure the distribution of mitochondrial mass in dividing HSCs and their progeny to 
assess a potential correlation with HSC fate choices. This analysis led to the conclusion that mito-
chondria are unequally distributed during single HSC divisions that are kinetically asynchronous. This 
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could suggest the existence of a mechanism that segregates mitochondria preferentially to one of 
the daughter cells during an asymmetric HSC division. 
Later in the thesis, a strategy is described to analyze the fate of daughter cells from HSCs that are 
activated and fate-instructed within the in vivo niche in the bone marrow of mice. This study led to 
the identification of a set of genes that are asymmetrically expressed between HSC daughter cells, 
both at the gene and the protein level. Furthermore, by combining two asymmetrically expressed 
markers, new phenotypes were identified that allow discrimination of a differentiated from a self-
renewing daughter HSC.  
Finally, the microchip platform was applied to study interactions between a single CD8+ T-lympho-
cyte and antigen-presenting cells (APCs), enabling an analysis of cell progeny derived from single T-
cells after activation. We successfully showed two types of interaction between a T-cell and the APC, 
namely, immunological synapse and kinapse. Furthermore, we observed that the protein expression 
is more asymmetric on daughter cells of the second generations than the first ones.  
Taken together, this thesis presents a novel system of single-cell analysis to study cell lineage rela-
tionships of rare and difficult-to-culture mammalian cell types, such as HSCs and T-lymphocytes. 
Reliable tracking combined with immunostaining enables the discovery of novel markers and mech-
anisms that can be used to identify distinct cell lineages and behaviors in vitro, opening up exciting 
perspectives for basic stem-cell biology and its clinical translation. 
 
Keywords  
single cell, cell tracking, lineage tracking, hematopoietic stem cells (HSCs), asymmetric cell division, 
T cells, stem cell fate, lineage analysis, asynchronous divisions, fatty acid oxidation (FAO), mitochon-
dria, peroxisomes, daughter cells, hydrogel 
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Résumé 
 
Les cellules souches hématopoïétiques (HSCs) permettent la production de toutes les cellules san-
guines, et ce, pendant la vie entière des individus. Cette capacité de régénération peut être utilisé 
en clinique pour traiter les troubles et maladies sanguines. Cependant malgré 60 ans de recherches, 
nous ne sommes toujours pas encore arrivés à utiliser toutes les vertus des HSCs pour guérir les 
maladies, et ceci est directement lié au nombre limité de HSCs que nous pouvons extraire de diffé-
rentes sources. Pour permettre d’utiliser les HSCs de façon optimale, il faudrait pouvoir les multi-
plier in vitro en laboratoire, mais cette pratique s’est montrée plus difficile que prévu. En effet, les 
HSCs perdent leur pouvoir thérapeutique lorsqu’elles sont cultivées in vitro. La raison principale de 
ce phénomène est liée au fait que nous ne sommes pas capables de reproduire l’environnement 
naturel des HSCs (la niche dans la moelle osseuse) qui leur est nécessaire pour effectuer leur travail. 
Pour pouvoir multiplier les HSCs in vitro, il faudrait d’abord comprendre comment la niche interagît 
avec les HSCs. De plus, lorsque les HSCs sont cultivées in vitro, elles perdent leurs marqueurs de 
cellules souches. Nous ne sommes donc plus capables d’identifier quelle cellule garde un pouvoir 
thérapeutique et laquelle se différencie en cellules sanguines matures. Ainsi, la seule méthode pour 
pouvoir dire quelle cellule est encore souche est de faire une transplantation dans un animal malade 
et de voir si la cellule est capable de régénérer le sang de l’animal, ce qui est une méthode très 
couteuse et longue. La solution pour trouver des marqueurs de cellules souches in vitro serait d’iso-
ler les cellules souches une à une et d’étudier leur descendance. De nombreuses plateformes d'ana-
lyse des HSCs au niveau de la cellule unique ont été créées, mais elles sont inutilisables dans le cadre 
des HSCs car ces plateformes se caractérisent par une viabilité cellulaire faible, d'un faible rende-
ment, d'un phénotypage non fiable par immunocytochimie et de la difficulté à mener une culture 
cellulaire à long terme. En outre, ces plateformes sont généralement fabriquées à partir de polydi-
méthylsiloxane (PDMS), un polymère connu pour avoir des effets négatifs sur les cellules. 
Cette thèse aborde et résout ces problèmes par le développement d’une nouvelle plateforme qui 
permet l’analyse de centaines de descendances de HSCs. Cette plateforme regroupe les avantages 
des plateformes microfluidiques où les cellules peuvent être encapsulées pour permettre l’obser-
vation des descendances, avec les avantages des plateformes à « puits microscopiques » qui per-
mettent l’étude de cellules fragiles. La plateforme est fabriquée à partir de deux couches différentes 
d’hydrogels qui ensemble permettent de créer une matrice de sillon fermée. Les cellules dans les 
sillons sont obligées de grandir et bouger selon un axe unique. Ce design permet donc de suivre les 
cellules de façon non ambiguë. Les deux couches d’hydrogels sont produites à partir de deux maté-
riaux différents : poly (2-hydroxyethyl méthacrylate) / triméthylolpropane triméthacrylate copoly-
mère (pHEMA-TMPTMA) et de polyéthylène glycol (PEG). Ces deux couches sont combinées après 
avoir préalablement déposé les cellules dans les sillons de la couche inférieure. Durant la fermeture 
de la plateforme les couches inférieures et supérieures sont collées de façon covalente par une ré-
action de type « chimie click » (par addition de Michael entre un thiol et un vinylsulfone). Les cul-
tures de HSCs sur plateforme ont été caractérisées par différents paramètres cellulaires comme le 
destin cellulaire, la prolifération, la fonctionnalité cellulaire.  
Résumé 
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Pour permettre une étude des descendances des cellules de façon rigoureuse et à haut débit, nous 
avons aussi développé un programme qui permet de créer des arbres généalogiques.  
Nous avons ensuite utilisé la plateforme pour observer la distribution des mitochondries dans les 
différentes descendances afin de mieux comprendre sa corrélation avec les choix du devenir des 
HSCs. Cette analyse a abouti à la conclusion que les mitochondries sont inégalement distribuées lors 
d'une division asymétrique des HSCs. Nous proposons ainsi l'existence d'un mécanisme de distribu-
tion spécifique qui sépare les mitochondries dans une cellule plutôt que dans une autre.  
Dans la partie suivante de la thèse, nous avons décrit une stratégie pour analyser le sort des cellules 
filles des HSCs ayant reçu une instruction de niche. Cette étude a conduit à l'identification d'un en-
semble de gènes exprimés de manière asymétrique au niveau protéinique entre les cellules filles. 
En combinant deux marqueurs exprimés de manière asymétrique, nous avons trouvé des phéno-
types pour définir quelle cellule fille s’est différenciée et quelle cellule fille est restée « souche ». 
Enfin, dans la dernière partie de la thèse, nous avons développé une nouvelle méthodologie qui 
permet non seulement l’étude de la synapse immunologique entre un lymphocyte T CD8 + naïf et 
une cellule présentatrice d’antigène (APC), mais aussi l’analyse de la descendance dérivée de la cel-
lule T après son activation. 
En résumé, cette thèse présente une nouvelle plateforme pour analyser les descendances des HSCs 
et des lymphocytes T. Un suivi fiable associé à une immunofluorescence a permis de découvrir des 
marqueurs et des mécanismes pouvant être utilisés pour identifier des différences de cellules dans 
la descendance de HSCs in vitro. De plus, nous avons également montré que la plateforme peut être 
utilisée pour aborder des questions fondamentales dans le domaine de l'immunologie. 
Mots-clés 
Cellule unique, analyse de la descendance, suivis de la descendance, cellule souche hématopoïé-
tique (HSCs), division asymétrique, cellule T, destin de cellule, division asynchrone, oxydation des 
acides gras, mitochondries, peroxysomes, cellules sœurs, hydrogel 
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Motivation and objectives 
 
Motivation 
During the past century, scientists discovered the remarkable ability of stem cells to give rise to all 
specialized cell types of a tissue, while at the same time producing more of themselves in a process 
termed self-renewal. This dual ability allows stem cells to maintain and repair tissues throughout 
the life of an organism and has made stem cells the prime cell type for clinical applications. In par-
ticular, hematopoietic stem cells (HSCs) were the first stem cell type to enter the clinics and are still 
very widely used for the treatment of leukemia and other blood disorders. In mice, even a single 
HSC is capable to reconstitute the entire blood system1. In mammals, adult HSCs are located in the 
bone marrow in a complex tissue environment called niche. Within the niche, the stem cells are 
exposed to external cues that dictate their fate, ensuring long-term self-renewal and blood produc-
tion. Removal of stem cells from their niche (e.g. such as in cell culture) results in rapid differentia-
tion. Numerous attempts to recreate HSC niche-like conditions in vitro, e.g. by testing cocktails of 
cytokines and growth factors2 or by mimicking the extracellular matrix (ECM) conditions found in 
the niche, have been tested but a robust HSC expansion without loss of therapeutic potential has 
been difficult to identify3,4. Clearly, a better understanding of the fundamental mechanisms that 
regulate HSC self-renewal at single cell level are key in order to fully exploit their clinical potential.  
Objectives and overview 
The overall goal of this thesis is the development of a technology for the precise analysis of the 
progeny of single HSCs. This platform should combine advantages of microfluidics devices, where 
cells can be encapsulated to allow lineage tracking, and the easy cell handling, high-throughput 
analysis and gentle cell deposition provided by microwell array technologies. Since HSCs are ex-
tremely rare cells (~1000 cells per mouse), this platform should also allow easy handling of these 
cells without significant cell loss. Finally, the platform should be user-friendly so that any laboratory 
can implement it without any expertise in the use of micro-devices. 
Chapter 1 of this thesis present an overview of the biology of the hematopoietic system. I also high-
light the importance of studying HSCs at the single cell level and existing approaches enabling the 
observation of cell lineages using micro-systems. 
Chapter 2 describes the development of an innovative high-throughput platform for single HSC lin-
eage tracking.  
Motivation and objectives 
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Manual single-cell tracking and lineage analysis is tedious and time-consuming. To allow fast and 
efficient analysis of lineages obtained using the platform described in chapter 2, an automated lin-
eage-tracking algorithm was created (Chapter 3). The algorithm automatically finds cells on images 
and associates them through frames, thus allowing the building of lineage trees. 
Chapter 4 reports the characterization of HSC culture on the microchip platform and also shows the 
monitoring of mitochondrial mass of HSC during culture. 
Chapter 5 presents an innovative methodology to discern differences in gene and protein expres-
sion between paired daughter cells after the first division. This analysis enabled the identification of 
novel markers that could be used to determine functional stem cells from committed progenitors 
during culture.  
Chapter 6 presents a new application of the platform in the area of T cell biology. The experiment 
consists of a co-culture of T cell and antigen-presenting cells, that enables the observation of the 
entire process from antigen presentation to a T cell, to its proliferation. The analysis suggests that 
the first initial divisions of T cells are asymmetric and give rise to two distinct lineages.  
Chapter 7 summarizes the studies performed in this thesis and discusses their relevance and out-
lines future perspectives. 
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 Introduction 
1.1 Hematopoietic stem cells 
Blood is a unique tissue that is responsible for multiple functions, such as carrying oxygen from the 
lungs to all other organs, helping them recover from bleeding, remodeling bones by removing dead 
cells and fighting infections from pathogens. All these functions are maintained by different special-
ized cells that need to be continuously replenished, due to their short life span. This homeostatic 
process of generation of blood cells is called “hematopoiesis”5. While many of these specialized cells 
circulate in the bloodstream, they originate from blood-forming environment, notably the bone 
marrow in adult mammals. Marrow is home to the most primitive cells of the blood tissue – the 
hematopoietic stem cells (HSCs) that are the ultimate and only source of all blood cells5,6. Although 
responsible for the regeneration of billions of new hematopoietic cells each day, HSCs are rare, with 
a proportion in the marrow of about 1 in 10,000 cells or in the bloodstream of 1 in 100,0007. To 
support the production of all blood cell lineages, HSCs first give rise to more proliferative cells, the 
short-term HSCs (ST-HSCs) and multipotent progenitor cells (MPPs). These multipotent progenitors 
generate large numbers of cells that progressively differentiate by first giving rise to lineage re-
stricted progenitors that themselves further divide and progressively differentiate to form all the 
specialized cells of the hematopoietic system (Figure 1.1) 8,9.  
The pool of HSCs decreases every time a cell is committed to differentiating, which would rapidly 
lead to HSC exhaustion. This phenomenon is counteracted by the capability of HSCs to self-renew 
(i.e., to produce more of themselves). It is noteworthy that this capacity is exclusive to HSCs and is 
lacking in progenitor cells, thereby making HSCs the only cells capable of long-term reconstitution 
of the blood tissue. The balance between differentiation and self-renewal determines the overall 
number of HSCs. This number of HSCs is finely controlled by a specialized environment called “the 
hematopoietic stem cells niche”. 
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1.1.1 The bone marrow niche 
The concept of the niche was proposed by Schofield in 197810 and can be defined as a specialized 
environment that promotes the maintenance of stem cells and regulates stem cell function11,12. The 
hematopoietic stem cell niche is composed of a multitude of different cells that nurture HSCs and 
provide cues that dictate HSC fate, namely quiescence, self-renewal, migration, apoptosis and dif-
ferentiation (Figure 1.2D). 
Observation of the localization of HSCs in tissue section (Figure 1.2A) revealed the existence of a 
“perivascular niche”, due to the presence of HSCs adjacent to sinusoidal blood vessels in the bone 
marrow and spleen13, and of an “endosteal niche”, due to the presence of HSCs at the interface of 
the bone and the marrow (Figure 1.2B)14. Different studies have shown the crucial role of niche-cells 
like mesenchymal stem cells (MSCs), endothelial cells, neural cells and osteoblasts in mediating 
HSCs’ fate. In the endosteal niche in particular, osteoblasts were shown to be important for the 
maintenance of HSCs and their survival by expressing different factors like angiopoietin, Wnt, Notch, 
thrombopoietin and osteopontin15–21. Using transgenic mice, Calvi et al. demonstrated that an in-
crease in osteoblast numbers induced HSC expansion, whereas osteoblast ablation resulted in a de-
crease of long-term HSCs’ self-renewal capacity and thereby reduced the HSC pool22,23. Other stud-
ies have revealed a subset of osteoblasts expressing the N-cadherin form N-cadherin/?-catenin 
 
Figure 1.1: The hematopoietic hierarchy. At the top of the hierarchy lies the most primitive population of the hematopoietic
system: The LT-HSCs (Long-term HSCs). These cells can self-renew and differentiate. This dual ability permits at the same time
to ensure lifelong blood production and protect HSCs from exhaustion. In contrast to LT-HSCs, ST-HSCs (Short-term HSCs)
exhibit more limited self-renewal potential. ST-HSCs give rise to MPPs (Multipotent progenitors) that are cycling regularly. 
The MPPs give rise to the oligopotent progenitors (megakaryocyte-erythrocyte progenitor: MEP, common myeloid progeni-
tor: CMP, lymphoid progenitor: CLP), and progenitors differentiate progressively into all the specialized cells of the blood
tissue. Image from 10. 
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complex with HSCs, perhaps mediating the attachment or adhesion of HSCs within the niche24. In 
the perivascular niche, CXCL12-abundant reticular cells (CAR) and MSCs were also shown to regulate 
HSCs’ fate. Ablation of these cells resulted in a severe decrease in HSC numbers25,26. 
In addition to cell-cell interactions and soluble signals, the niche also provides “physical factors” 
such as oxygen tension27,28. Parmar et al. stained HSCs with a chemical marker for hypoxia and 
demonstrated that HSCs are in an hypoxic environment and are themselves hypoxic29. Spencer et 
al. performed measurements on the oxygen tension in the bone marrow niche and found that the 
oxygen tension is indeed low in the bone marrow30. In line with these results, other groups have 
shown that hypoxia inducible factor (HIF1?) – a regulator of oxygen homeostasis ? is up-regulated 
in HSCs31. HIF1? was shown to promote HSCs’ quiescence and maintenance32. Interestingly, HIF1??
indirectly prevents pyruvate from entering the tricarboxylic acid cycle (TCA), thus blocking mito-
chondrial respiration32 , making glycolysis the main energy source for HSCs32,33. 
 
 
1.1.2 HSCs in the clinic 
The regenerative potential of HSCs in humans was demonstrated in 1956, when the first bone mar-
row transplant was successfully performed to rescue a patient suffering from leukemia34. Marrow 
transplantation is still the procedure of choice today to treat blood-related diseases7. Clinical esti-
mations reported that 40,000 transplantations were performed in Europe in 201435. However, bone 
Figure 1.2: The bone marrow, the HSC niche, and HSCs’ fate. (A) On the left, a cross-section of a mouse femur showing parts of the
bone and the marrow. On the right, an image of the vasculature (sinusoid in purple, arterioles in green, and transition vessels in
blue) and HSCs (stained in yellow). Adapted from11. (B) Scheme of the two HSC niches – the endosteal niche and the vascular niche.
The HSCs in the endosteal niche reside in a very hypoxic environment and are mostly in a quiescent state. The extracellular matrix
(ECM) and the CXCL12-abundant reticular cells (CAR) seem to keep HSCs in a state of dormancy. In the vascular niche, activated HSCs 
are mostly located near the sinusoid, where HSC progenies are able to enter the bloodstream. Adapted from14. (C)-(D) Scheme of
extrinsic cues in the niche that dictate HSCs’ fate choices. Fate choices can be (1) quiescence or migration, (2) asymmetric division, 
(3) symmetric commitment, (4) symmetric self-renewal. Adapted from233. 
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marrow transplantation efficiency is currently limited due to the high doses of HSCs required to 
achieve the rapid and sustained engraftment that is critical for patient survival and recovery36. The 
rate of mortality is therefore still high and ranges between 7% for patients with acute leukemia in 
remission and 27% for patients with refractory acute leukemia (100 days post transplantation)34. 
Moreover, 8?10% of the patients who survive for 2 years without disease relapse fail to survive due 
to hematopoietic failure34. 
Currently, the widespread application of HSCs to treat patients is severely restricted by the low 
number of cells that can be isolated from umbilical cord blood7. HSC expansion in vitro is therefore 
considered a potential solution that held great promise in clinics, but it has proven to be difficult to 
implement37. 
1.1.3 HSC expansion in vitro 
As previously mentioned, methods that would be beneficial for the treatment of blood disorders 
require pre-amplification of HSCs in vitro while retaining HSCs’ healing potential. Attempts to ex-
pand these cells have never resulted in a significant expansion of HSCs, unlike other types of stem 
cells, such as neurons stem cells, intestinal stem cells and embryonic stem cells, where expansion is 
routinely performed7. When HSCs are cultured in vitro, they rapidly differentiate as early as the first 
initial divisions and lose their stem properties38. The reasons lie in the fact that in vitro cultures are 
not able to recapitulate the bone marrow niche. Lack of critical cues from the niche pushes HSCs to 
a “default” fate of differentiation toward committed progenitors7. Despite considerable effort to 
understand the fundamental mechanisms underlying HSCs’ fate choices, we are currently still una-
ble to expand HSCs ex vivo. Fundamental biological mechanisms need to be understood in order to 
fully control HSC expansion through in vitro culture. Although HSC expansion is not yet possible over 
the long term, extensive efforts have been made to culture mouse HSCs. During the past decades, 
several proteins and chemicals have been identified for their actions supporting ex vivo expansion 
of hematopoietic progenitors. Stem cell factor (SCF) is one of the most important factors mediating 
HSCs’ self-renewal39. Thrombopoietin (TPO) was described to be essential for HSCs and its genetic 
elimination leads to reduction of HSCs40,41. Serum-free culture supplemented by SCF and TPO has 
been shown to support survival and proliferation of HSCs. In contrast, other cytokines including IL3, 
IL6, IL11 and Flt3 ligand in combination with either SCF and/or TPO have been reported to mediate 
rapid HSC proliferation associated with a loss of long-term reconstitution potential42. In vitro treat-
ment with Wnt3a has also been shown to promote HSCs’ expansion43. However, conditional expres-
sion of ?-catenin, an intracellular transducer of Wnt signaling, revealed impaired multilineage dif-
ferentiation and transient increase in HSC numbers followed by exhaustion of the HSC pool44,45. 
Moreover, different pathways regulate important aspects of HSC maintenance. The TGF-b/smad 
signaling was shown to be a crucial pathway for maintenance of HSC quiescence46. Another im-
portant actor that prevents HSC differentiation and helps in HSC expansion in vitro is the Notch 
signaling pathways47. Suzuki et al. demonstrated that supplementation of Delta 1 (Notch ligand) 
with SCF, TPO, Flt3, IL3, IL6 in a serum-free medium resulted in a six-fold increase in the cell num-
bers. Intriguingly, Chiba et al. have reported that only small quantities/concentrations of Notch lig-
and support cord blood expansion and that high quantities/concentrations of Notch ligand induce 
apoptosis’, if this satisfies your intended meaning.47,48. 
As previously explained, HSCs reside in a hypoxic niche, which imposes dramatic changes in their 
metabolic status in comparison to progenitor cells49. It was recently demonstrated that modulation 
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of the metabolism via exposure to certain drugs could modulate HSC fate. Vannini et al. demon-
strated that lowering the mitochondrial potential by drug-induced uncoupling of mitochondrial elec-
tron transport chain drives self-renewal in vitro50. Importantly, the authors also showed that low 
mitochondrial potential marks functional HSCs in vitro. Ito et al. performed another notable study 
controlling HSCs’ fate. They artificially induced a metabolic switch through the activation of mito-
chondrial fatty acid oxidation (FAO), which resulted in an increase of asymmetric divisions (HSCs’ 
maintenance)51. In contrast, when FAO was inhibited a loss of HSCs’ self-renewal capacity was ob-
served.  
1.1.4 Markers defining HSCs 
A variety of markers have been discovered to reliably identify functional HSCs when extracted from 
the murine bone marrow. The gold standard to assess whether a population is enriched in HSCs is 
to test the capacity of cells to reconstitute the blood tissue of a lethally irradiated mouse. The first 
markers in the field were based on the cellular size and density in combination with Hoechst stain-
ing52. Since then, major efforts have been undertaken to find a cell surface marker that can be used 
for HSC isolation by flow cytometry. For the mouse model, a set of markers allows the identification 
of all specialized hematopoietic cell lineages (defined as Lin). Within the Lin- (negative selection of 
Lin), HSCs were initially shown to reside in the positive fraction of cKit (cKit+) and Sca (Sca+), a pop-
ulation known as LKS (Lin-cKit+Sca+)53. LKS and CD34 negative population was shown to enrich for 
functional HSCs but was later shown to be a highly heterogenous populations, as demonstrated by 
long-term blood reconstitution assay1. Different markers have been identified in subsequent years 
to improve HSC enrichment, especially since the introduction of the SLAM family markers (CD150 
and CD48), which highly improved the purity of HSCs54,55. 
A commonly used combination of these markers to purify functional HSCs is LKS CD34- 
CD150+CD48- 14. Other combinations allow identification of early progenitors in the hematopoietic 
hierarchy by upregulation of both CD34 and CD48 (ST-HSCs) or by a down-regulation of CD150 
(MPPs) 14. Importantly, Zhang et al. demonstrated that these markers used to sort fresh HSCs or 
progenitor cells are expressed differently during culture in vitro37, and become unreliable. 
1.2 Micro-device for analysis at the single cell level 
Living tissues are formed by different cell types, and the assumption was that each cell type has a 
distinct function, lineage and fate56. Single cell studies have revealed that this assumption is incor-
rect. While a population of a cell type might be identical morphologically or have similar phenotype, 
this population is made up of individual cells that differ dramatically57. Therefore, analysis of an 
entire cell population results in averaged measurements, and hides cell-cell variations within the 
population57. Cell-cell variations might have important consequences in the functioning and health 
of a tissue. A relevant example was demonstrated by Sato et al., who used HeLa cells ? a presumably 
homogeneous cancer cell line ? and revealed that only a small subset of cells can self-renew and are 
responsible for the replenishment of the entire colony58. It is understood that single cell analysis 
allows precise measurement of cell populations by considering that each cell is unique; however, 
analysis at the single cell level is often a challenge. Until recently, single cell studies have been lim-
ited by the cost and throughput required to examine large numbers of cells. These issues are even 
more challenging when the starting population of cells to be analyzed is rare (e.g., HSCs, circulating 
tumor cells)57,59. These limitations and roadblocks inspired scientists to fabricate new tools to enable 
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observation at the single cell level, in high throughput and at low cost. In the following sections, I 
present methods that enable single analysis. 
1.2.1 Cell tracking using conventional culture method 
The isolation of single cells from an entire cell population should be performed in such a way that 
cells preserve their biological integrity56. The most straightforward and probably easiest method 
involves only gravity, of letting cells in suspension fall onto a flat substrate. Once cells have reached 
the bottom of the plate, single cells are tracked using time-lapse microscope. This method enables 
lineage tracking60, immunofluorescence staining analysis (only with adherent cells) 61, and protein 
expression analysis when cells are genetically modified and express a reporter gene62. Recently, Al-
ber et al. combined this approach with genetically modified cells to measure synthesis and degra-
dation rates of endogenous protein in embryonic stem cells (ESCs)63. 
The main disadvantages of this method were: (1) cell movement in all directions, resulting in a mix-
up of all lineages, (2) the requirement of using adherent cells, (3) cells had to be imaged quite fre-
quently (2-4 min) to not lose single cell tracking64, (4) formation of cell aggregates that prevent single 
cell analysis, (5) single cell analysis could only be performed reliably as long as cells were isolated 
from one another and could be treated as non-interacting single cells65, (6) low throughput. 
The limitations of the above culture system have spurred the development of numerous cell culture 
platforms using state-of-the-art microfabrication technologies. The term microfabrication involves 
the implementation of miniaturized structures at the micron scale using techniques such as photo-
lithography, soft lithography, laser ablation, embossing and micromachining66. 
1.2.2 Single cell tracking using microwell arrays – “Passive platforms” 
One of the most common platforms for single cell analysis is the microwell array67,68. Microwell 
arrays are topographically structured surfaces of “opened” micron-sized chambers (i.e., microwell) 
(Figure 1.3A). Microwells can be made in different materials including bulk polymer69,70, polymer 
hydrogels68 and even glass71. Microwells vary in size and height depending on the application, al-
lowing single cell isolation by sedimentation (gravity). After cell seeding each microwell will contain 
the lineage derived from one single cell. 
Advantages of microwell arrays are countless, due to their ease of fabrication combined with their 
high versatility in terms of modification. Possible modifications include: biomolecules anchoring on 
the microwell surface, stiffness of the material, shape of the microwells and proteolytic degradation 
of the substrate63,68,72. 
In the context of stem cells, microwell array tethered with biomolecule can be used to mimic some 
components of the in vivo niche. The so-called “artificial niche” in the microwell arrays is combined 
with single cell imaging to asses change of behavior of stem cells 68,73. To ultimately prove that the 
“artificial niche” has a positive effect on the stem cells (i.e., it protects stem cells from loss of stem-
ness), the functionality of cells must be tested via transplantation into a sick host 68,73. 
It is important to note that adherent cells can migrate away from their initial captured microwell. 
To support adherent cells’ culture onto microwell array the substrate should prevent cell adhesion 
in order to avoid cells overcoming the topographical barrier74. Typical non-adhesive substrates in-
clude agarose and poly(ethylene glycol) (PEG) hydrogels68,75. 
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To minimize cell handling and increase the single cell capture efficiency in one microwell, Lindström 
et al. developed a method where each cell can be placed at an exact position76. To this end, they 
combined a microwell platform placed on a motorized stage with a conventional flow cytometer. 
The motorized stage permitted precise movement of the microwell platform so that each cell that 
was ejected from the cytometer arrived in a different microwell76. This technique is especially inter-
esting when dealing with a small number of cells. Despite clear advantages over conventional mam-
malian cell culture substrates, microwell arrays have some limitations: (1) Microwell arrays are “pas-
sive” platforms, medium cannot be changed easily because any perturbation would flush cells away, 
(2) The movements of cells in microwells make it difficult to track individual cells, (3) Post-culture 
assay (i.e., immunocytochemistry) is not possible for the same reasons as in (1). 
1.2.3 Single cell analysis using flow-based platform - “Active platforms” 
Alternative approaches have addressed the microwell limitations by using microfluidic platforms. 
Microfluidics is a generic term describing platforms that contain a pattern of micro channels. The 
ensemble of micro channels forms the “microfluidic network” that is connected to the macro-envi-
ronment by holes. For single cell analysis, the microfluidic network is used to direct cells in suspen-
sion into individual cavities where they are cultured individually. 
Park and others enabled single analysis on a microfluidic platform by merging the microwell array 
platform with a channel network placed on top of the microwells77,78. In this platform, the flow 
pushes cells in the top channel horizontally and by gravitational force cells are gently directed ver-
tically until they reach the microwells at the bottom. However, trapping efficacy is quite low in such 
platforms. By adding a valve at both entrance and exit of the top channel, Jan et al. were able to 
interrupt the flow, which allowed cells to sediment more freely in the microwells, yielding better 
capture efficiency77. Based on the same concept, Lecault et al. designed a platform to enable long-
term culture of HSCs. The perfusion of the device at different times with a medium containing SCF 
(i.e stem cell factor) made it possible to observe when the stimulation by stem cell factor was first 
required for HSCs to exit their quiescent state79. It is noteworthy that the platform of Lecault, is the 
only one allowing HSC culture over the long term in the presence of flow. 
Figure 1.3: Microwell technology. (A) PEG microwell arrays allow single cell studies in high throughput. Each well of the 96- 
well plate contained 400 microwells made in PEG hydrogel. (B) Example of a strategy to anchor biologically active biomole-
cules on the PEG microwell surface. This technique allows the presentation of “niche-like” candidates to cells and conse-
quently to study the specific role of biomolecules in HSCs’ fate decisions. Image from149. 
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Other groups focused on the efficiency and throughput of single cell trapping in microfluidic devices. 
Dino Di Carlo, Tan and Takeuchi, pioneers in the field, created two different trapping devices using 
flow streamlines to direct single cells into a small unit usually called a “hydrodynamic trap”. Arrays 
of hydrodynamic traps can be generated, facilitating high-throughput single cell analysis 80–86. How-
ever, many of these devices do not allow observation of cell progenies due to lack of space in the 
hydrodynamic traps. Consequently, other groups combined hydrodynamic traps with microwells 
placed next to the hydrodynamic traps. This modification permitted observation of the entire cell 
lineage, migration and differentiation87–89. Another solution to observe cell lineages is to isolate 
daughter cells after division in downstream hydrodynamic traps82,90. 
Other platforms using hydrodynamic traps have been shown to enable on-chip or off-chip RT-qPCR 
for single cell gene analysis82,91,92. Other approaches to single cell capture use external forces to 
retain cells in desired positions produced by dielectrophoresis force (DEP) optical tweezers, mag-
netic and acoustic waves 93–97or pico-liter droplets98.  
Figure 1.4: Microfluidics-based devices for single cell trapping. (A) Microwells (or chambers in the image, in pink) are con-
nected to a network of channels (in blue). The channel network is placed on top of the microwells, therefore cells can sedi-
ment from the channel into the microwells. Each microwell will contain one colony derived from one single cell. The depth
of the microwell prevents cells escaping or being flushed away during perfusion. Image adapted from80. (B) Hydrodynamic 
trap array. Flow streamlines direct cells into the traps. It follows a change of flow-resistance through the hydrodynamic traps 
that prevents additional cells being captured in the same traps. (C-D) Platforms with alternative designs of hydrodynamic
traps91. (D) Hydrodynamic traps array allowing ultra-high throughput of single cell analysis87. 
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1.2.4 Lineage tracking platform for HSCs  
Single cell lineage tracking provides useful biological data, such as proliferation kinetics and single 
cell lineage tree construction. Lineage trees are necessary to unambiguously decode differential re-
sponses of a single cell in distinct states64,99. This is particularly interesting to implement in the frame 
of stem cells, in order to study the different cell types that can arise from the initial mother cell100. 
Analyzing stem cell progenies is an old approach that was already performed in 1905 by Conklin et 
al.101. However, modern techniques revolutionized the field by allowing direct observation of gene 
or protein expression in the progeny via fluorescent reporter gene or protein quantification via im-
munofluorescence staining. Lineage tracking can be achieved in vitro and in vivo, but here the focus 
is only on in vitro techniques. 
The most straightforward approach that enables lineage tracking in vitro is to seed cells on a con-
ventional culture plate and to acquire images at regular time intervals. However, it has to be con-
sidered that cells are usually motile, which has the following consequences: (1) Tracking can become 
ambiguous, especially if the frequency of acquisition is not high enough to resolve cell movement 
precisely, (2) Progenies from two distinct single cells can be mixed, (3) Cells can exit the field of view. 
Issues (1) and (2) can be resolved by imaging cells every 2-4 min and by seeding cells at a low con-
centration, so that one FOV contains only one progeny60. Problem (3) can be fixed only by using 
another culture approach (like a microwell array platform as indicated previously). For this reason, 
this approach has the disadvantage of having a very low throughput while creating an enormous 
number of images. Nevertheless, pioneers in the field have used this approach to analyze line-
age60,102,103 of mesodermal cells giving rise to endothelial cells and blood colonies. Through this ex-
periment the authors demonstrated that a progeny of blood cells can have as ancestors hemogenic 
endothelial cells60. To cope with the large amount of data generated in such experiments, they cre-
ated a computer-based algorithm that automatically builds lineage trees. The limitation of such a 
system is that the tracking algorithm requires fluorescent images to detect cells and it is combined 
with a high rate of image acquisition. This leads to phototoxicity and cell death in the long term. 
Establishment of novel tools to study lineages without the requirement of frequently imaging cells 
and without fluorescent reporters to track cells would be highly beneficial. This problem was ad-
dressed by Rowat et al., who used an elegant strategy to capture single cells and observe their 
progenies using a microfluidic platform. Briefly, single mother cells are directed into a long, rectan-
gular trapping channel and captured at the extremity of this channel by a hydrodynamic trap89. Be-
cause the trapping channel is long and narrow, daughter cells are forced to grow in a line, which 
allows unambiguous progeny tracking (Figure 1.5A). An equivalent method consists of isolating cell 
progeny after each division in downstream trapping units82,104 . Another strategy was proposed by 
Moffitt et al., who proposed seeding bacteria onto a platform containing long tracks, followed by 
encapsulation of the cells with an agarose lid (Figure 1.5B)105. Similar to Rowat’s platform, cells were 
forced to grow in line, which allowed reliable tracking. 
Despite the number of microfluidics platforms that allow single cell trapping, only an extremely 
small number of them support long-term culture, probably due to the fact that cells suffer from 
shear stress and die. The most successful idea was probably the hydrodynamics traps, but this de-
vice fails to support fragile cells such as HSCs, probably due to the deleterious damage resulting 
from shear stress106,107. 
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Figure 1.5: Single cell trapping device that allow progeny tracking. (A) (Left) Individual yeast cells are captured by an hydro-
dynamic traps and cultured in a long channel. The width and height of the channel are calculated so that cells are con-
strained and must grow in line, ensuring unambiguous lineage tracking. (Right) Measurements of protein expression on 
individual yeast. Images from89  (B) Lineage tracking of yeast in an agarose hydrogel and polydimethylsiloxane (PDMS) 
platform. Here bacteria are captured by sedimentation and encapsulated in grooves. Similarly to (A) unambiguous tracking 
is enabled by constraining cell so that they must grow in line. Image from 105 
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 Hydrogel-based groove array for 
lineage tracking of rare and fragile single cells
Abstract  
Single cell isolation, followed by tracking of the progeny over a long period of time, has proved to be challenging. Key 
difficulties of this task involve the necessity of continuous and frequent visualization of cellular dynamics for several 
days in a row, the need of a platform that would allow unambiguous tracking of cell lineages, and the requirement of a 
reliable methodology of single cell isolation which would not affect the survival or fate of the cell. Here, we introduce a 
novel gravity-based single cell, multi-lineage tracking platform, designed for working with rare and fragile cells (<1-10k). 
To achieve single cell capture and its lineage tracking, we have developed a new type of closed rectangular chamber, 
produced from two distinct hydrogel materials: poly(2-hydroxyethyl methacrylate)-trimethylolpropane trimethacrylate 
copolymer (pHEMA-TMPTMA) and self-assembling poly(ethylene glycol) (PEG). This chamber encapsulates an array of 
grooves, in which single cells are cultured. Single cells are restricted to growing in a line inside the same, unique grooves 
of the platform, to which they were seeded at the beginning of the experiment. Such a design enables unambiguous 
tracking of a single cell and its progeny. The gravity-based cell seeding method allows protection of the cells from the 
deleterious mechanical stress of a flow-based trapping system and also to achieve highly efficient single cell capture. 
The permeable nature of porous hydrogel material facilitates access of the cells to the nutrients of the culture medium, 
opening up the possibility of long-running experiments, including tracking of multiple generations of single cell progeny. 
To evaluate the potential of this platform, we applied it to investigation of the proliferation kinetics and peroxisomal 
protein expression levels within the independent lineages of single, non-adherent primitive hematopoietic stem cells 
(HSCs). 
2.1 Introduction 
Precise analysis of the key processes controlling the fate of a single stem cell and its lineage is an 
essential step towards understanding the fundamental processes taking place in stem cells. This 
knowledge is valuable for their successful application in regenerative medicine. However, single 
stem cell isolation and progeny tracking has proved to be challenging, especially when the initial 
material is rare57. 
A common strategy for progeny tracking involves the isolation of mother cells in individual cham-
bers. After the mother cell division, its daughter cells are then constrained in a long chamber and 
grow in a line89,88,105 or, alternatively, are captured in the downstream trapping units82,104. Such de-
vices allow unambiguous tracking of the cell progeny. However, in the majority of microfluidic de-
vices hydrodynamic traps are implemented to capture single cells to a chamber, where the flow 
continuously pushes them, thus minimizing cell escape81. While this approach is effective for single 
cell isolation, such devices have some practical disadvantages, especially in work involving experi-
ments with rare and sensitive cells. Firstly, cell loss during transportation from macro- to micro- 
environments is considerable108; secondly, the flow tends to induce mechanical shear stress, which 
is deleterious for stem cell survival and might bias its fate in the long term. To reduce shear stress, 
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the flow rate could be decreased, but this usually leads to the formation of bubbles in the microflu-
idic network due to water evaporation through the PDMS pores109. A remarkable microfluidic de-
vice, developed by Lecault et al.110, partially solves these problems by supporting HSC expansion via 
gravity-based isolation of cells into deep squared chambers containing microwells, where at the 
bottom of the microwell shear stress is minimized. Thus, at the end of the experiment each mi-
crowell contains a colony of cells derived from a single cell. This device is similar to the platform, 
based on array of microwells, that also uses gravity to trap cells inside the small cavities, where they 
divide111. Significantly, in the case of experiments with rare and fragile cell types, microwell array-
based platforms provide several practical advantages, such as minimizing the number of cells lost 
during the transfer from the macro- to micro-environment; passive nutrient delivery to the cells 
(i.e., without creation of an active flow), which greatly improves cell viability; and the possibility of 
high-throughput analysis112,76. However, in the last two examples microcolonies are not spatially 
organized. This disadvantage imposes a requirement of very frequent (if not continuous) imaging to 
allow efficient cell progeny tracking. For the same reason, microwell array-based approaches would 
not allow fixation and further workup of the cells, which is necessary for analysis of protein expres-
sion by immunofluorescent staining. 
The primary goal of this work was to improve existing approaches to the tracking of single cells and 
their progeny by combining the advantages of passive (i.e., without use of fluidics) devices, such as 
microwell arrays, with the benefits of closed platform such as a microfluidic device, where cells are 
spatially organized, allowing unambiguous tracking of the cell progeny. Importantly, such an ap-
proach would make possible the correlation of the experimental data obtained by tracking of single 
live cells with the data on protein expression levels in the same cells that can be gained by fixation 
and immunofluorescent staining. We have strived, therefore, to develop a microgroove-based plat-
form, which can be closed after the cell seeding step to protect the cells from escaping from the 
initial groove or from interchanging their relative positions as well as to preclude the loss of the 
fixed cells after fixation. Crucially, such closure should not lead to any impairment of cell viability. 
However, platform closure in the presence of cells is a difficult task, due to the fact that such a 
procedure could potentially be harmful to live cells. PDMS bonding, for example, is achieved by 
activating surfaces via oxygen plasma treatment, a lethal procedure for cells113. Alternative poly-
mers, that offer other bonding approaches, were recently developed. In particular, robust strategies 
of covalent chemical bonding of layers via “click” chemistry provide numerous advantages114,115. 
These chemical reactions are efficient, selective and can be easily implemented in the context of 
different substrates. Efficient bonding of two polymers in particular can be achieved in a one-step 
fashion, when one polymer exhibits excess of thiol groups on its surface and the other excess of the 
complementary thiol-reactive groups116. Thus, we have chosen to implement thiol-vinylsulfone Mi-
chael reaction as the method of platform closure in the presence of cells. This reaction is particularly 
interesting, because it occurs near physiological pH and temperature117,118. 
To validate the potential of our platform design, we have used it to track the division kinetics of 
single hematopoietic stem cells (HSCs) and correlated this information to the levels of peroxisomal 
protein PMP70 expression in the same cells. 
Additionally, our platform design allows the cell-contacting surface of the polymer to be readily 
coated with bioactive molecules. We have demonstrated the proof of this concept by modifying the 
surface with fluorescent FITC-BSA protein. 
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2.2 Materials and methods 
2.2.1 pHEMA-TMPTMA groove platform fabrication 
Azobisisobutyronitrile (AIBN), 2-Hydroxyethyl methacrylate (HEMA), Trimethylolpropane tri-
methacrylate (TMPTMA), Pentaerythritol tetraacrylate (PETA), Acetic acid, (3-Mercaptopropyl)tri-
methoxysilane (MPS), acetic acid (AA),  Tributylphosphine were all purchased from Sigma Aldrich 
Switzerland and were used as received, if not specified. Tetrahydrofuran (THF) (Sigma) was dried 
under molecular sieves before use. 
2.2.2 Preparation of acrylate-modified glass slide 
12mm glass slides were subjected to liquid phase salinization in order to derivatize their surfaces 
with acrylate functional groups (Supplementary Figure S2.1A). Slides were placed into the holding 
rack and immersed in a close tank, containing a solution of 4% MPS and 3% of aqueous acetic acid 
(1:10 AA:H2O volume ratio) in ethanol. Glass slides were incubated overnight at 80°C in oven in the 
N2 atmosphere. They were further rinsed thoroughly with ethanol and dried in N2 flow at 80°C for 
15min or overnight at RT, then immediately immersed in a solution of 0.05% tributylphosphine and 
2.5% PETA in THF and allowed to react at room temperature under argon atmosphere for 30min. 
Derivatized glass slides were washed in THF and dried at RT. Derivatized slides were used for further 
steps within 2 days. 
2.2.3 Preparation of groove array, based on pHEMA-TMPTMA hydrogel polymer (bottom part 
of the platform) 
pHEMA-TMPTMA was polymerized on 0.13mm thick glass slide (Corning Glass), derivatized with 
acrylate groups to ensure optimal adhesion between the glass surface and polymer (Figure 2.1A, 
Supplementary Figure S2.1A). Bulk pHEMA-TMPTMA hydrogel was prepared by radical polymeriza-
tion at 70°C in oven with N2 flow, using a reaction mixture, consisting of HEMA, TMPTMA, ddH20 
and AIBN in the following volume ratios: 88.5:10:1:0.5. The solution was mixed and purged with N2 
for 5minutes and directly poured onto PDMS stamps. Standard soft lithography processes were im-
plemented to create PDMS stamps. They were directly cast on silicon wafer, reproducing the desired 
pattern of rectangular pillars. The acrylate-derivatized glass slides were placed onto a 5-10uL drop 
of polymerization mixture (Figure 2.1B). Polymerization was performed for 24h. Upon completion 
of polymerization, PDMS stamp was peeled off from the cross-linked hydrogel, the resulting plat-
forms were washed with THF in order to remove residual monomers and dried in a chemical hood 
overnight prior to the next steps. 
2.2.4 pHEMA-TMPTMA surface characterization 
Surface topography of pHEMA was measured on the WYKO NT 1100 optical profilometer (Veeco, 
Plainview, NY) and scanning electron microscope (SEM) Zeiss LEO 1550 for more precise structural 
observation. 
2.2.5 Derivatization of the hydrogel surface with functional groups or proteins 
The free hydroxyl groups of pHEMA-TMPTMA hydrogel were derivatized with tricholotriazine (TCT), 
introducing electrophilic dichlorotriazine moieties to the polymer surface and making it reactive to 
various nucleophiles (Supplementary Figure S2.1B). Briefly, platforms were immersed in a solution, 
containing 2% TCT and 4% DIPEA in THF, placed into a desiccator and allowed to react for 30min 
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under stirring under argon atmosphere at RT. Upon reaction completion, the platforms were 
washed 3 times with THF and then ddH20.  
A two-step reaction was further used to covalently bind nucleophile-bearing molecules to the acti-
vated pHEMA-TMPTMA hydrogel surface (Supplementary Figure S2.1B). The triazine ring-bound 
chlorines can be substituted in a stepwise manner, based on the strength of the corresponding nu-
cleophile and temperature of the reaction119. 
2.2.6 Derivatization with thiols 
The activated platforms were immersed in a buffered solution (PBS, pH 7), containing 3% dithio-
threitol (DTT), under argon atmosphere. After 3 days of incubation, the platforms were washed 3 
times with PBS (pH 5.5) and immersed in acidic PBS buffer (pH 5.5) at 4°C to protect thiols from 
oxidation until use. To prove the presence of covalently-bound thiols on the resulting hydrogel sur-
face, DTT-derivatized platforms were incubated with the solution of thiol-reactive fluorophore Cell 
Tracker Violet (Thermofisher). Unspecific binding of the fluorescent dye was controlled by compar-
ison to the results, obtained by incubation of the non-DTT-derivatized pHEMA-TMPTMA hydrogel 
with Cell Tracker Violet solution under same conditions (Figure 2.3). 
2.2.7 Surface immobilization of proteins (proof-of-concept experiment) 
A solution of 1% (w/w) FITC-labelled BSA (Sigma Aldrich, Switzerland) (pH 7.4) was reacted overnight 
with TCT-derivatized pHEMA-TMPTMA surface to demonstrate the possibility of covalent binding of 
the protein molecules to the activated hydrogel surface. Unspecific binding of the protein was con-
trolled by comparison to the results, obtained by incubation of the non-TCT-derivatized pHEMA-
TMPTMA hydrogel with FITC-labelled BSA solution under same conditions (Figure 2.3). 
2.2.8 Confocal imaging 
Z-stack images at 60x of grooves were acquired using confocal microscope (slices thickness=0.3um, 
Nikon Ti-Z, crest spinning disc) and 3D reconstructions were performed using imageJ. 
2.2.9 Preparation of PEG hydrogel-based lid (top part of the platform) 
To create a lid, which is permeable for cell culture nutrients, and which can be used in the combina-
tion with the bottom part (thiol-bearing pHEMA-TMPTMA hydrogel) to close the platform, prevent-
ing the live cells from escaping from the grooves, electrophilic thiol-reacting PEG hydrogel was pre-
pared according to Lutolf and al120. PEG polymer was produced through reaction of 10kDa 4-arm-
PEG-TH and 20kDa 4-arm-PEG-VS precursors, mixed to the final concentration of 2.5% total PEG in 
a triethanolamine buffer 0.03M (pH 7.7)121. Polymerization of PEG was achieved by spreading 10uL 
of precursor mixture onto the 9mm glass slides, which were previously immerged in a solution of 
polyvinyl alcohol (PVA) and then dried at RT. To ensure the presence of free vinylsulfone groups 
within the resulting hydrogel, the molar ratio between PEG-thiol (PEG-TH) and PEG-vinylsulfone 
(PEG-VS) precursors was adjusted to 40% excess of PEG-VS. This allowed to achieve the closure of 
the platform through the covalent binding of the surfaces, based on the Michael addition of thiols 
of the bottom part to the vinylsulfone groups of the top part (Figure 2.1C). 
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Figure 2.1:
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2.2.10 Platform closure 
The platform closure was performed by carefully placing a glass slide, containing the PEG lid, onto 
pHEMA-TMPTMA hydrogel-based bottom part, containing the groove array with the previously 
seeded live cells.  The platform was further immersed in a PBS buffered solution (pH 8) at RT and 
centrifuged at 5g for 15min to allow the Michael addition to occur. After that the glass substrate 
was carefully removed from the lid and the resulting closed platform with encapsulated live cells 
was washed 3 times with the standard culture medium. 
2.2.11 HSCs extraction 
Hematopoietic stem and progenitor cells were isolated from crushed bone marrow of 8-16 weeks 
C57Bl/6 mice. Erythroid cells were eliminated by incubation with red blood cell lysis buffer (Bio-
legend). Lineage depletion (CD3, B220, Ter-119, CD11, Gr-1) was performed using the Hematopoi-
etic Progenitor Cell Enrichment set (BD Biosciences). Cells were stained with SAV-PO (Life Technol-
ogies), Kit-PE-CY7 (2B8, BioLegend), Sca1-PE (D7, BioLegend), CD150-BV784 (TC15-12F12.2, Bio-
Legend), CD48-PB (GM48-1, BioLegend), CD34-eF660 (RAM34), eBioscience). LT-HSCs were sorted 
?????????-???????????????????????????????????????-HSCs as LKS CD150+ CD34+ and MPP as LKS 
CD150-CD34+. 
2.2.12 Cell culture and time-lapse image acquisition 
After extraction, cells were seeded onto the platform and time-lapse microscopy was performed. 
Cells were imaged every 30min or 1h. HSCs were cultured in serum free medium (StemlineII, Sigma-
Aldrich, St. Louis, USA) supplemented with 100ng/ml stem cell factor (SCF) and 2ng/ml Flt-3 ligand 
(R&D Systems, Minneapolis, USA). PPAR-? agonist (GW501516, Sigma Aldrich) was supplemented 
at a concentration of 20nM, if needed.  
2.2.13 Immunofluorescent staining and confocal imaging 
At the end of culture, cells were fixed in 2% PFA and permeablized with 0.1% TritonX. Cells were 
stained with anti-PMP70 antibody (Abcam). Z-stack images were acquired at a magnification of 60x 
using a Visitron CSU-W1 confocal spinning disk microscope. 
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2.3 Results and discussion 
2.3.1 Platform concept 
To study single cell progeny, we developed a hybrid hydrogel-based platform to create a closed 
array of grooves that enables precise tracking and analysis of the lineage of single cells, including 
rare, non-adherent stem cells. Our strategy primarily focused on the gentle handling of cells during 
their trapping and culture, but also on the practical ease of manipulation of a small number of sen-
sitive cells. The concept of the device is based on the microfluidic platform presented by Rowat in 
2009. Briefly, single mother cells are directed into a long, rectangular trapping channel, in which 
daughter cells are forced to grow in a line89. To be able to close the device to achieve encapsulation 
of single cells inside the individual grooves, we selected PEG-based hydrogel as a highly permeable 
top layer (lid) and pHEMA-TMPTMA-based hydrogel as a bottom layer to serve as the basis for a 
rigid groove structure. In our device design, nutrients can passively diffuse through hydrogel pores 
and reach the cells trapped in the grooves. This allows us to avoid the recurrent problems of PDMS- 
and flow-based devices57,109, mentioned earlier. 
 
 
Figure 2.2: 
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2.3.2 Platform fabrication 
We have designed a device based on rectangular microgrooves array, to facilitate the lineage track-
ing of a rare cell population and allow convenient analysis (Figure 2.2G and Figure 2.3A). The plat-
form fabrication relies on separate production of a bottom and a top part. These parts are produced 
from two chemically different hydrogel materials: the bottom part from 2-hydroxyethyl methylacry-
late/trimethylolpropane trimethacrylate copolymer (pHEMA-TMPTMA) and the top part (lid) from 
self-assembling poly(ethylene glycol)  (PEG) (Figure 2.1B-C). These two parts are combined together 
after the live cells are seeded into the grooves of the bottom part. During the closure of the platform 
the top and bottom parts are covalently bonded to each other through the use of click-chemistry 
(thiol-vinylsulfone Michael reaction). pHEMA-TMPTMA hydrogel is much stiffer and provides a ro-
bust mechanical structure for the cell-encapsulating groove compartment of the bottom part. In 
contrast, the PEG lid is soft and permeable for cell culture nutrients, thus allowing them to reach 
live cells during the course of the experiment. This combination of mechanical durability and easy 
supply of nutrients opens up the possibility of carrying over lineage tracking experiments for multi-
ple generations of a single cell progeny. 
 
 
Figure 2.3: pHEMA-TMPTMA surface characterization and derivatization. (A) A photograph of the bottom part of the plat-
form made of a glass coverslip with a layer of pHEMA-TMPTMA polymer, containing 4300 micro-grooves. A small coin is 
shown in the photograph for scale. (B) 3D shape reconstruction of the platform grooves, obtained by optical profilometry.
(C-D) 3D reconstruction of confocal images of the platform grooves, after BSA-FITC was allowed to react with dichlorotria-
zine moieties on the TCT-derivatized pHEMA-TMPTMA surface. (E-F) TCT-derivatized pHEMA-TMPTMA polymer was allowed 
to react with DTT for 72h (1), 24h (2), 1h (3), or not reacted. 
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Groove dimensions were optimized to suit the tracking of single hematopoietic stem or progenitor 
cell. The width of the groove (12um) was chosen in order to prevent the possibility of two daughter 
cells interchanging their relative positions (Figure 2.2B-E). This condition is mandatory for the sub-
sequent unambiguous tracking of a single cell lineage tree. 
PDMS was chosen as an inert mold for bottom part production during pHEMA-TMPTMA polymeri-
zation. A potential problem with the usage of PDMS material could be mild adhesion of the PDMS 
mold to the pHEMA-TMPTMA upon the completion of polymerization. Such an eventuality could 
hypothetically introduce mechanical defects into the groove features, when the PDMS is peeled 
from the polymerized pHEMA-TMPTMA. To check whether such a problem had occurred, the quality 
of surface topography of the pHEMA-TMPTMA polymer, obtained after the PDMS mold was peeled 
off, was characterized with an optical profilometer and SEM imaging. As illustrated in Figure 2.3B, 
the groove features do not show any significant defects. Closer inspection of the SEM images (Sup-
plementary Figure S2.2) shows that even submicron structural features of the PDMS mold, which 
appeared as the consequence of the previous production step, are preserved on the surface of the 
groove wall, proving that the structural quality of the resulting pHEMA-TMPTMA grooves can be 
reliably reproduced. 
On its own, pHEMA-TMPTMA hydrogel does not possess the ability to covalently bind biologically 
active molecules, while such surface modifications could be used to customize the properties of the 
material to achieve optimal culture conditions for a variety of cell types. It is also necessary to be 
able to derivatize the polymer surface with the free thiol groups to facilitate the possibility of sub-
sequent closure of the platform. These requirements can be met through activation of the surface 
of pHEMA-TMPTMA polymer with sufficiently reactive electrophilic moieties, to which various nu-
cleophiles could be covalently anchored. To achieve that, we utilized a two-step chemical modifica-
tion of pHEMA-TMPTMA surface. First, the pHEMA-TMPTMA polymer was treated with TCT to deri-
vatize the hydroxyl groups of polymer surface with the reactive dichlorotriazine moieties (Supple-
mentary Figure S2.1B). This renders the polymer surface reactive towards various nucleophiles. Di-
chlorotriazine moieties can be subsequently substituted with DTT to introduce thiols or with amine- 
or thiol-containing biological molecules (e.g., proteins). Successful activation of pHEMA-TMPTMA 
with TCT was proven by immobilization of fluorescent FITC-BSA protein on the polymer surface (Fig-
ure 2.3C-D). Similarly, to prove the successful derivatization of the surface with thiols, surface im-
mobilization of the thiol-reactive fluorophore Cell Tracker Violet was demonstrated (Figure 2.3E-F). 
In both cases the intensity of the fluorescence signal detected for the modified polymer surface was 
much higher in comparison to the underivatized polymer. 
Our platform is aimed at permitting a precise, image-based analysis of the progeny of a single cell 
at high magnification. Since the high magnification light microscope objectives have a relatively nar-
row working distance range, the distance between the cells and objective must be as small as pos-
sible. This can be achieved by minimizing the thickness of the polymer at the bottom of the grooves 
within pHEMA-TMPTMA hydrogel. This problem was successfully solved by spreading 5 to 10ul of 
pre-polymerized mixture on a circular PDMS mold approximately 8mm in diameter. It was noticed 
that during polymerization part of the material was lost due to evaporation; however, this did not 
introduce significant practical problems for further imaging experiments, performed with 60x mag-
nification objective (Figure 2.5B). Another complication was caused by the fact that, when pHEMA-
TMPTMA polymer was produced on a non-modified glass cover slip surface, it tended to crack and 
delaminate from the cover slip during the cell culture experiments within 24 hours. This precluded 
the possibility of long-term cell tracking experiments. We hypothesize that mechanical stress, re-
sulting from the swelling of the hydrogel immersed in water, and low natural affinity of pHEMA-
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TMPTMA to the glass are the reasons for this phenomenon. A similar problem was observed for 
another HEMA-based polymer in a previously published study122. Therefore, we chemically modified 
the glass surface, derivatizing it with free acrylate moieties, to which the pHEMA-TMPTMA can be 
cross-linked during the polymerization (Supplementary Figure 2.1A). First, a silane coupling agent 
(MPS) was used to modify the glass cover slip surface with free thiols, and the pentaerythritol acry-
late (PETA) was used to react with the resulting thiol groups, introducing free acrylate groups to the 
surface of the glass cover slip (Supplementary Figure S2.1A). When the polymerization of pHEMA-
TMPTMA was performed on such an activated glass surface, no delamination occurred during the 
cell culture experiments. A few microscopic cracks within the polymer can still be observed (as seen 
in Figure 2.4B), which can be explained by the residual mechanical tension in the material during 
the swelling; however, these minor cracks do not create any practical problems for further live cell 
experiments. 
The covalent bonding of the top and bottom parts of the platform (platform closure) was performed 
through the Michael reaction between thiol groups introduced to pHEMA-TMPTMA surface and vi-
nylsulfone groups present on the PEG lid (Figure 2.1C). The rate of this reaction increases with pH, 
but to optimize the cell viability during the platform closure the buffer pH was set to 7.7117. We have 
observed that sufficient adhesion between top and bottom parts of the platform occurred after 
15min in these conditions. Prior to platform closure, the mixture of PEG precursors is allowed to 
crosslink on a glass substrate to provide the support for convenient manual manipulation of the lid. 
However, removing the polymerized PEG lid from the glass surface without damaging it in these 
conditions proved to be difficult. Therefore, a pre-coating of the glass cover slip surface with a sac-
rificial layer of polyvinyl alcohol (PVA) was implemented, in accordance with Nelson123. As PVA rap-
idly dissolves in water-based medium after immersion, this approach allows easy detachment of the 
glass from the PEG lid. In the optimized procedure of the platform closure, a glass cover slip with an 
attached PEG lid is carefully placed on top of the bottom layer with the subsequent removal of the 
cover slip by a horizontal sliding motion. This method avoids damage to the platform structure or 
the entrapped cells. The adhesion force between the PEG and pHEMA-TMPTMA must be sufficient 
to sustain external mechanical forces during the cell culture experiments and post-culture assays, 
involving multiple changes of the media. Therefore, we tested the strength of adhesion by mimick-
ing mechanical stress through pipetting of the culture medium up and down in the proximity of the 
closed platform lid. These tests showed that in the majority of cases the lid stayed in place. Differ-
ences in adhesion strength are likely caused by human technique errors during the lid deposition 
step. 
2.3.3 Cell culture and multi-lineage tracking 
The applicability of the platform for practical biological assays was tested on murine hematopoietic 
stem cell (LT-HSCs, ST-HSCs) and progenitor populations (MPP). These cells are widely recognized 
to be fragile and extremely sensitive to external stress57,124, presenting significant technical chal-
lenges for the platforms which are used to study them. To our knowledge, no experimental data 
involving the multi-lineage tracking of a single cell progeny was reported for the most primitive 
hematopoietic stem cell population (LT-HSCs). Thus, we strived to implement our closable micro-
groove-based approach for the culture of HSCs. 
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The number of cells seeded into the platform at the beginning of a typical biological experiment was 
significantly smaller than the number of corresponding grooves in the platform. This allowed achiev-
ing the situation where, following the seeding step, most of the grooves initially contained just a 
single cell inside (Figure 2.2G). We checked whether the encapsulation of HSCs impairs their survival. 
We also analyzed the viability of HSCs following 3 days of culture in our platform. The cells demon-
strated good viability (>75% with LT-HSCs, >90% with ST-HSCs and MPP) in these conditions. More 
detailed analysis showed that most cell death events happened at the beginning of the experiment, 
shortly after the cells were seeded into the grooves. This suggests that these cells were damaged 
during the multiple manipulations prior to seeding. Overall, the viability analysis suggests that the 
culture inside the platform does not induce significant cell death in HSCs. Multi-lineage cell tracking 
and the cell division analysis were performed following bright field time-lapse microscopy, when the 
images were acquired every 30min or 1h. Efficient tracking of the kinetics of cell division within a 
Figure 2.4: Multi-lineage tracking of single hematopoietic stem cells and proliferation kinetics analysis of HSC populations. (A) Rep-
resentative images obtained during time-lapse microscopy of single LT-HSCs. (B-C) Single cell dividing up to the 3rd generation with 
corresponding lineage tree. (D) Average proliferation rates, measured for live single cells of 3 different populations of HSCs: ST-, LT- 
HSCs and MPP. As expected, the most primitive cells (LT and ST) exhibit slower kinetics, compared to MPP. Percentage of dead 
cells: MPP=0%, ST-HSCs=9.5%, LT-HSCs=25.3%, (red, MPP; blue, ST-HSCs; green, LT-HSCs). (E) Cumulative histogram of time spent 
until first division for indicated population (red, MPP; blue, ST-HSCs; green, LT-HSCs). (F) Cumulative histogram of time between 
the first and second divisions (red, MPP; blue, ST-HSCs; green, LT-HSCs). Number of live single cells for LT-HSCs n=74, ST-HSCs n=67, 
MPP n=45.  
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groove was achieved in all experimental conditions (Figure 2.4A-B). In particular, we did not observe 
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the phenomenon of “cell escaping”, where a cell, initially seeded into one groove is moved to an-
other, or when the cells “jump” on top of one another, interchanging their relative position within 
the same groove. Hence, it can be concluded that the platform with the closed lid ensures that the 
cells are securely encapsulated inside the grooves and grow reliably in line. It was previously shown 
that LT-HSCs gives rise to HSCs with more-limited self-renewal potential (ST-HSCs) and ST-HSCs fur-
ther differentiate to generate multipotent progenitors (MPPs). While the LT-HSCs remain mostly in 
a quiescent state, ST-HSCs and especially MPPs divide more frequently125,126. We compared the pro-
liferation kinetics of these three populations to assess whether the platform changed the prolifera-
tive behavior of these populations of cells (Fig. 4D-F). In line with previous study, the number of 
divisions changed dramatically from the LT-HSCs to MPPs with concomitant increase as we moved 
down in the hematopoietic hierarchy73. 
2.3.4 Temporal and phenotypic information mapping 
To demonstrate the possibility of acquisition of the biologically relevant data during the cell culture 
experiments in our platform, we have correlated the kinetics of single live cell divisions (temporal 
mapping) with the distribution of the peroxisomal protein PMP70 between the pairs of daughter 
cells (phenotypic mapping) at the end of the 3-day long cell culture experiment (Figure 2.5). The 
phenotypic mapping is achieved by immunofluorescent staining of fixed cells, and the temporal in-
formation mapping is derived from time-lapse imaging of live cells. Thus, to correlate the kinetic and 
phenotypic information for the same cells, it is obligatory that the exact spatial positions of the cells 
can be unambiguously defined throughout the analysis of the experimental data. To demonstrate 
that our approach allows efficient preservation of the cells inside the same grooves within a plat-
form to which they were seeded initially, throughout all washing and staining steps necessary for 
the immunofluorescent staining, we cultured HSCs for 1 day, fixed them and stained the cells with 
the anti-PMP70 antibody. Remarkably, even after multiple washing and incubation steps, cells re-
mained at their initial positions, as illustrated in Figure 2.5B. Having proved that our platform can 
be used for the correlation of the temporal and phenotypic information within the same cells, we 
used this assay to study asymmetric division in HSCs. Such asymmetric division gives rise to two 
functionally distinct progenies of the same mother cell127. It was previously shown that PPAR-? ac-
tivation with GW501516 agonist increases the number of asymmetric division events in LT-HSCs128 
Figure 2.5 Temporal and phenotypic information mapping. (A) (1) Single cells inside the grooves are tracked by bright field
microscopy imaging at low magnification (10x). (2-3) Corresponding lineage trees are extracted from time-lapse images.
(4) The cells are fixed and processed for immunofluorescent staining. (5) Confocal fluorescent imaging of fixed cells is per-
formed at high magnification (60x). (6) Finally, temporal and phenotypic information is correlated. (B) HSCs are cultured 
for 24h, then fixed, stained with PMP70 (red) and Hoechst (blue), and Z-stacks of confocal fluorescent images are acquired 
(60x magnification). Cells remained at their initial positions after culture and staining, enabling correlation of phenotypic
and temporal information mapping. Scale bar = 25 ?m. (C) HSCs were cultured either in the presence of PPAR-? agonist 
(GW501516), or not. An increase of temporally asymmetric divisions (33% to 48% in untreated and treated populations, 
respectively) was observed. (D) PMP70 protein expression (representing peroxisomal mass) was quantified in several HSC 
generations (G0, G1, G2, G3: zero, first, second and third order generation, respectively). (E) Quantification of PMP70 signal 
intensity (representing peroxisomal mass) for cousin cells was correlated to temporally asymmetric and symmetric divi-
sions. (C,E,F) For each pair of cousin cells (depicted in green or red on schemes), index of symmetry of peroxisomal mass
distribution was calculated as a ratio as follows: (?)???????? = ????(???????)?????(???????)???? (???????)  , with ????(??????1) >
????(??????2). (G-H) PMP70 staining of cells. Images show the sum of pixels along z-axis. Error bars represent SD, n=232
cells (GW501516 treated cells), n=248 cells (control). Statistical analysis was performed by one-way ANOVA and Bonferroni
post-Hoc test. ***p< 0.001 
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(i.e., where one cell retained stem cell phenotype and the other acquired more committed pheno-
type) in vitro, and that this phenomenon is associated with an increase of fatty acid oxidation 
(FAO)128. Therefore, we used PPAR-? activation as a way to induce asymmetric division in LT-HSCs 
cultured in our platform, and analyzed the temporal and phenotypic information during these divi-
sions. We hypothesized that peroxisomes might be distributed non-homogeneously in asymmetri-
cally dividing HSCs and may influence the fate of the daughter cells derived from the same mother 
HSC. In congruence with this hypothesis, we found that comparison of cousin cells (defined as two 
daughter cells derived from two different mother cells, while these mother cells themselves are 
derived from the same cell, see also Figure 2.5E) showed significant increase in the asymmetry of 
peroxisome distribution in the cells undergoing temporally asymmetric divisions. We defined as 
temporally asymmetric those divisions in which, within the pair of two daughter cells derived from 
the same mother cell, at least one cell had divided, and necessarily within at least 6h since this 
division the second daughter cell had not yet divided (Figure 2.5C). Such temporally asymmetric 
divisions have been proposed to be a phenomenon associated with increasing rate of asymmetric 
stem cell divisions129. Additionally, when the cells treated with GW501516 were compared to non-
treated cells, the frequency of temporally asymmetric divisions was higher in cells exposed to 
GW501516 (Figure 2.5C). Analysis of the PMP70 protein expression in several cell generations also 
revealed that the cellular peroxisomal mass is increased after one division in the GW501516-treated 
cells, but with significant subsequent decrease in the following generations (Figure 2.5D). These 
findings suggest that peroxisomes may indeed play an important role in HSC fate decision; however, 
the exact mechanisms behind this influence are still not clear.  
Overall, the correlation between temporal and phenotypic information (cell division kinetics and 
peroxisomal mass distribution, respectively) suggests that peroxisomes are non-homogenously dis-
tributed during asymmetric division in LT-HSCs. 
2.4 Conclusions 
The general aim of the present study was to design and investigate a new cell culture platform, 
which enables single cell tracking and multi-lineage progeny analysis for a small number of sensitive 
cells. We were able to successfully culture HSCs, overcoming the major challenges that had proved 
to be problematic for most previously developed devices. In contrast to previous approaches that 
require complicated tubing, micro-pumps and other expensive instruments to achieve cell progeny 
tracking, the platform presented here is not based on fluidics and is simple to use. It relies only on 
gravity to trap the single cells inside the closable microgrooves. The platform can be modified to 
track the progeny of other cell types, and the length of the grooves can be readily extended for 
longer-term cell tracking. Finally, we have shown the proof-of-concept possibility of modification of 
the cell-contacting surface of the hydrogel with protein molecules. Such surface modification can 
be used to influence the fate of cultured cells via numerous bioactive cues. 
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Figure S 2.1: (A) Derivatization of the glass cover slip in order to obtain acrylate groups on the surface. (B) General
approach for pHEMA-TMPTMA functionalization with thiol or proteins. Chlorine substitution with hydroxyl groups 
occurs on the pHEMA-TMPTMA polymer surface. Then biomolecules or DTT is added and second chlorine substitu-
tion occurs. 
Figure S 2.2: Surface topography of pHEMA-TMPTMA obtained via scanning electron microscopy (SEM).
Red arrow shows sub-micron ridges in the groove that were produced as a consequence of the previous
production step. 
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 Automated algorithm for the 
lineage tracking of single hematopoietic stem 
cells 
Abstract  
In vitro experiments based on tracking of single cells and their lineages provide useful biological data, such as prolifera-
tion kinetics and single cell lineage tree construction. Additionally, these experiments allow following the movements 
of the cells, detection of changes in their size as well as registering cell death events. The tracking is generally performed 
by acquiring images at fixed time intervals using time-lapse microscopic imaging. This method generates a large number 
of images, and the manual analysis of this data is tedious and time-consuming. Today, computer-based algorithms are 
capable of performing single cell tracking, which is followed by automatic construction of the lineage tree. Such algo-
rithms are usually designed to excel in analysis of a particular type of experimental data, and often perform poorly with 
other types of data. Here, we implemented a semi-automated method for detection, tracking and construction of the 
lineage trees for single hematopoietic stem cells (HSCs). The algorithm was specifically designed to be used in combina-
tion with a micro-groove array platform that enables high-throughput lineage tracking of the single cells. Our algorithm 
provided robust and efficient cell detection, while the average error in cell tracking accuracy was only 0.03 per 100 
images. We demonstrated the usability of this tool for practical biological applications by analyzing the behavior of HSCs 
exposed to three different drugs. The preliminary data obtained in these experiments encourages further investigation 
of the importance of peroxisomal fatty acid oxidation in HSCs. 
3.1 Introduction 
Time-lapse microscopy allows temporal measurement of critical events or processes that take place 
during the life of a cell, such as mitosis, migration, morphological changes, interactions with other 
cells and death99,130. Tracking cell progenies over several generations allows building of the lineage 
trees, in which every cell division represents a new branch and cell death results in the termination 
of a branch2. Lineage trees provide useful information on division dynamics, cellular phenotype and 
fate. Such data is particularly valuable for studying hematopoietic stem cells (HSCs). Indeed, the 
nature of the single HSC lineages was shown to be intertwined, to some extent, with their respective 
fate choices (i.e., self-renewal, differentiation, quiescence and death)58,73,111,129,130. Lineage tree 
analysis during the exposure of HSCs to various drugs would be ideal to reveal how these drugs 
influence HSCs’ fate. It was recently demonstrated that modulation of the metabolism via exposure 
to certain drugs could modulate HSC fate; consequently, the potential to manipulate HSC expansion 
in vitro in a way that allows preservation of their healing potential for clinical applications provides 
an exciting field for further research32,50,51,131. However, there are currently no reliable in vitro tech-
nologies that allow tracking HSCs and analyzing their lineages automatically in a high-throughput 
fashion. 
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Construction of the single cell lineages by tracking the cells through visual image inspection is a 
tedious task, because it requires visualization and manual linking of the lineage-related cells in hun-
dreds of thousands of images. Such an approach not only greatly limits the throughput of the 
method, but is also highly prone to human error. Thus, several lineage tracking programs have been 
developed in recent years, which aim to perform automatic lineage tracking132–136. Common steps 
include preprocessing the image data, applying a segmentation algorithm to separate the cells from 
the background, associating cells between successive time points (i.e., frames) and analyzing output 
data133,134,137. Tracking algorithms are dependent on specific parameters, that are usually accurate 
only for a given problem and therefore are likely to fail for another one. A representative example 
involves the detection of cell division across various cell types. In the case of adherent cells like 
fibroblasts, the shape of the cells is a reliable readout, because fibroblasts undergoing mitosis be-
come round. Hence measuring the circularity of a cell, frame by frame, provides sufficient infor-
mation for confident detection of the cell division132. In contrast, non-adherent cells like HSCs prac-
tically do not change their shape during mitosis, which makes it problematic to determine which 
cells have divided and which have not. Moreover, the time interval between two image acquisitions 
needs to be small enough to resolve cellular shape changes (i.e., 4-5 min)60. A time-lapse interval of 
4-5 min is not suitable for experiments that last for days or demand the observation of a small num-
ber of cells, due to the number of images generated for each experiment99. Another interesting 
aspect that deserves consideration is the cell culture setup. In conventional culture, cells can freely 
move and divide in all directions. Therefore, during time-lapse experiments, when images are ac-
quired at a fixed position it is likely that the cells would enter or exit the field of view (FOV). In the 
case of an exit, the follow-up of the cell is interrupted and the subsequent lineage of this cell is lost. 
A cell that enters the FOV cannot be considered, as its previous proliferating history is unknown. 
The main challenge for the algorithm, in this case, is to discriminate whether a certain cell has di-
vided or a new cell has entered the FOV. In fact, if the number of cells in the FOV has diminished, 
the algorithm is challenged to distinguish between the cell death event and the exit of a certain cell 
from the current FOV. These events lead to tracking errors and increase the complexity of problems 
that must be overcome to develop a robust tracking algorithm137. One possible solution is to change 
the field of view, following the moving cell, but this is not possible if one wants to follow more than 
one cell or an entire cell lineage, because certain daughter cells might move in the opposite direction 
in comparison to the mother cell. Alternatively, instead of increasing the algorithm complexity, the 
culture platform itself can be modified, for example by constraining cells into micro chambers138. 
Not only does this remove the problem of cells entering and exiting the FOV, but it also keeps single 
cell lineages isolated from others. Indeed, in such conditions a microwell would contain colonies, 
deriving exclusively from a unique cell57,139. Nevertheless, although this approach solves the afore-
mentioned problems, lineage tracking is by no means trivial to achieve in the context of microwells, 
due to the possibility of movement of the cells in all directions. This imposes a demand for very 
frequent, if not continuous, image acquisition, in order to precisely track cells. 
Here we aimed to solve these limitations by combining a state-of-the-art culture platform with the 
development of a tracking software, tailored for HSCs. The platform contains a micro-groove array 
that enables HSC culture during long-term experiments with lineage tracking (Trachsel et al., Sub-
mitted). In contrast to microwell-based approach, micro-grooves constrain cells on all axes except 
one, which forces cells to grow and move in line. Therefore, it allows studying the lineages derived 
from single HSCs, unambiguously, even if image acquisition is performed infrequently. In regard to 
implementation of the tracking algorithm, the use of a micro-groove approach diminished the com-
plexity of the algorithm, while retaining all the key capabilities of a lineage tracking program (i.e., 
building of the lineage trees, monitoring of the cellular size and movements). Unlike other tracking 
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algorithms that need optimization of a few parameters before being able to do cell tracking132, here 
we implemented a program that by default doesn’t need any user intervention for tracking HSCs.  
The purpose of this study was primarily to facilitate the tracking and analysis of the lineages derived 
from single HSCs, by combining the algorithm, specifically designed for HSC detection, with the ad-
vantages of the micro-groove platform. We assessed our algorithm by analyzing 55 single HSCs, cul-
tured during 85h (during which time ~200 frames per sequence were acquired). A sequence (or 
image sequence) represents all images acquired during the experiment at a particular position. We 
found an average tracking accuracy error of 0.03 per 100 frames. To validate the potential of our 
approach we performed a multi-dimensional assay, where we automatically measured the prolifer-
ation kinetics and cell morphology and detected the events of differentiation into megakaryocytes 
for 163 HSCs exposed to three different drugs that specifically affect their metabolism. We found a 
notable difference in HSC behavior between the studied conditions. This finding highlights the prac-
tical utility of our approach. 
We believe that our automatic tracking algorithm, combined with the micro-groove technology, is 
a powerful tool to decipher HSC fate decisions, especially in the context of drug screening. Such an 
approach would help to understand fundamental mechanisms underlying HSCs’ fate choice. 
3.2 Materials and Methods 
3.2.1 Isolation of LT-HSCs 
Hematopoietic stem and progenitor cells were isolated from crushed bone marrow of 8-16 weeks 
C57Bl/6 mice. Erythroid cells were eliminated by incubation with red blood cell lysis buffer (Bio-
legend). Lineage depletion (CD3, B220, Ter-119, CD11, Gr-1) was performed using the Hematopoi-
etic Progenitor Cell Enrichment set (BD Biosciences). Cells were stained with SAV-PO (Life Technol-
ogies), Kit-PE-CY7 (2B8, BioLegend), Sca1-PE (D7, BioLegend), CD150-BV784 (TC15-12F12.2, Bio-
Legend), CD48-PB (GM48-1, BioLegend), CD34-eF660 (RAM34), eBioscience). LT-HSCs were sorted 
?????????-???????????????????????????????????????????????????-HSCs as LKS CD150+ CD34+ and 
MPP as LKS CD150- CD34+. After extraction, cells were seeded onto platformsm, and time-lapse 
microscopic imaging was performed. HSCs were cultured in a serum free medium StemlineII (Sigma-
Aldrich, St. Louis, USA), supplemented with 100ng/ml stem cell factor (SCF) and 2ng/ml Flt-3 ligand 
(R&D Systems, Minneapolis, USA). For the drug screening assay, 20nM of PPAR-? agonist (GW50516, 
SigmaAldrich) or antagonist (GSK0660, SigmaAldrich), or 20nM of 10,12-tricosadiynoic acid (TDYA, 
SigmaAldrich) were present in the medium.  
3.2.2 Time-lapse microscopy 
Micro-groove arrays were fabricated and used as described (Trachsel et al., Submitted). Freshly iso-
lated HSCs and multipotent progenitors were cultured in the platform for 85h. Cells were imaged 
every 15, 30min or 1h using a Zeiss Observer microscope. 
3.2.3 Automated cell tracking and reconstruction of the lineage tree 
The program was written in Java language and used as a plugin in ImageJ and can be obtained on 
demand.   
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3.2.4 Statistical analysis 
Pairwise comparisons were performed using Student’s t test and multi-comparaisons by one-way 
Anova followed by Bonferroni’s test. 
3.3 Results and discussion 
3.3.1 Development of an automated lineage tracking algorithm for HSC analysis 
To follow single cells and their progeny in vitro, we used a platform that forces the cells to grow in 
line (Trachsel et al.). We acquired images over 85h using a time-lapse microscope. We also devel-
oped an automated system that is able to find cells and cell-cell association over frames (i.e., 
through image sequences). We tested the robustness of our algorithm by experimental tracking of 
single HSCs. The main steps of the program are schematically shown in Figure 3.1. Briefly, grooves, 
containing single cells, were manually selected with a single mouse click per groove. This selection 
is the only non-automatic step of the procedure. The images are then segmented to detect cells. 
The segmentation involves a feedback loop that adjusts the process in order to minimize detection 
error. Once cells are detected, a comparison of the number of cells between neighboring frames 
allows the detection of cell division or cell death events. Finally, cell-cell associations are completed 
and the program saves the extracted data (i.e., lineage tree, cellular size, cell position (centroid), 
tracking robustness index (that is the value of the matching function described below), cell differ-
entiation into megakaryocyte). We applied the program to 55 image sequences (with a total number 
of ~11,000 images) and obtained an accuracy of 0.05±0.001 errors per 100 frames. 
3.3.2 Cell segmentation 
Cell segmentation is probably the most important step in the algorithm for cell tracking. It consists 
of partitioning an image into multiple sets of pixels. Obviously, the objective here is to extract pixels, 
representing the cells, and to convert the images into binary masks. A straightforward approach is 
to use the difference of intensity between a cell and its surroundings by applying an intensity thresh-
old. For this purpose, segmentation can be achieved by using the bright field or fluorescent images. 
An advantage of fluorescent over the bright field image is the high signal to noise ratio of the cellular 
area in comparison to the background. Typically, fluorescent dyes such as Qtracker®, CellTracker® 
or fluorescent protein reporters are used for lineage analysis140,141. However, exposure of cells to 
high intensity light (required for the excitation of the fluorophore) might induce stress and delete-
rious cellular damage (i.e., phototoxicity), including the production of reactive oxygen species (ROS) 
and free radicals64,103. It is especially important to minimize phototoxicity in the case of sensitive 
cells such as HSCs142. HSCs are highly susceptible to an elevated ROS level32. In contrast, bright field 
image acquisition involves softer light exposure, but produces poorly contrasted images which may 
cause inconsistent segmentation. Therefore, there exists a controversy  
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as to the requirements of image quality for cell segmentation and cell health during image acquisi-
tion64. We found an excellent compromise by implementing a method that permitted producing 
highly contrasted images of HSCs by collecting bright field images at three different z-positions (z-
stack). We noticed that an image of HSC, acquired 10?m above (defined as A1) or below (A3) a cell 
center, produced a darker or brighter spot, compared to the same cell in focus (A2) (Figure 3.2A). 
By applying a gaussian blur (defined as ?) and then a standard deviation projection (STD) to the z-
stack, we obtained the projected images, where the cells became bright (high STD) whereas the 
background area consisted of dark pixels (low STD). We applied an adaptive intensity threshold143 
to segment cells (Figure 3.1B(4)) and obtained a binary image “C1”. We found that this method was 
extremely robust in finding the cells, but could also introduce false positive areas (pixels, that were 
falsely considered as cells) due to the high STD value in the area between two cells that are close to 
each other. To eliminate these areas, we applied a gaussian blur on image A3 and found its local 
maxima (Figure 3.2B(5)). Then we selected only the areas from C1 in which local maxima were found 
(Figure 3.2B(7)). We further filtered unwanted areas by applying thresholds to the size and circular-
ity of segmented areas, which typically eliminated particles (dust) that would be falsely considered 
as cells otherwise.  
 
Figure 3.1: Schematic description of the algorithm with its output data. The algorithm consists of six modules: 1. Manual groove 
selection (ROI selection), 2. Segmentation, 3. Cell detection (with feedback loop), 4. Cell mitosis/death detection, followed by 5. Cell 
linking. Finally, image sequences and lineage tree of the tracking are created. The boxes on the left illustrate the feedback loop and 
boxes on the right the outputs provided by the algorithm. 
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We implemented a “control” feedback loop that compared the number of segmented areas found 
in a frame at a time interval t to those in the previous frame at a time interval t-1 (respectively 
defined as Nt and Nt-1), as illustrated in Figure 3.3. We considered three different scenarios: 1) when 
Nt = Nt-1, cells only moved, and the program continued; 2) when Nt > Nt-1, division(s) occurred; 3) 
when Nt < Nt-1, either a false negative event happened or a cell died. A false negative event happens 
when a cell is rejected by the size or circularity threshold during segmentation. If the falsely rejected 
cell has a size or circularity that is very close to the threshold value, it is possible to find these cells 
by increasing or decreasing the gaussian blur ?. The Gaussian blur slightly changes the size and cir-
cularity of the segmented areas. Therefore, the feedback loop incrementally changes the gaussian 
blur ? by a step that can be changed if necessary by the user (±??), and compares the number of 
cells Nt and Nt-1. If Nt becomes equal to Nt-1, the algorithm concludes that a cell was found,  
Figure 3.2: Schematic description of the segmentation process. (A) Time-lapse microscopy is used to generate image sequences 
of a single cell and its progeny. Three images per z-stack are acquired with a step of ±10um from the cell center in focus. (B) Z-
stacks are processed in order to extract cells from the background. Raw images (1) are blurred (2) and standard deviation is 
applied on the z-stack (3). Cells are segmented via an intensity threshold (“Yen-threshold”143) (4). In parallel local maxima are 
found (5-6) and added to the thresholded image (4) in order to discard false positive areas (7-8).  
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the new number of cells is validated, and the 
algorithm continues. If Nt is still lower than 
Nt-1 despite the change in the blur value, the 
program concludes that “the missing cell” is 
not a false negative, but a cell that died (dy-
ing or dead cells are usually small and/or dark 
and are rejected by the algorithm) (Figure 
3.3).  
We analyzed 55 representative image se-
quences (i.e., 11,000 frames), in which we 
observed all fates seen during HSC culture in 
vitro (Figure 3.4), and found error of segmen-
tation in 1.8% of these image sequences 
(0.009±0.0001 errors per 100 frames). After 
visual inspection of the movies, we observed 
that problems appeared when a cell died af-
ter it had divided. The error is probably due 
to a wrong conclusion of the feedback loop, 
that may occur in case of division events and 
cell death. We also assessed whether the 
segmentation looks different, if HSCs had 
proliferated, died or differentiated into MK, 
or remained quiescent (Figure 3.4). The segmentation was consistent throughout the sequence of 
frames for all conditions, with the exception of MK cells (Figure 3.4), where the segmentation did 
not always produce accurate areas.  
3.3.3 Detection of the differentiation into megakaryocytes 
As previously mentioned, some HSCs differentiated into large cells that were considered as 
megakaryocytes (MK, Chapter 3 of this thesis and 111). We implemented our program to detect MKs 
by applying a size threshold, above which a cell is considered as MK. By default, a cell is detected as 
MK when its initial size has increased by 30% (this threshold is tunable). MKs were manually identi-
fied in image sequences and the results were compared to the algorithm outputs. We obtained a 
MK detection specificity of 85% (i.e., true negative rate) and a sensitivity of 88% (i.e., true positive 
rate).  
3.3.4 Cell linking 
Cell linking is a process that iteratively associates a cell from one frame to the same cell or its daugh-
ter cells in the next frame. There are two general approaches to finding the good association of cells, 
using images. The first involves segmenting the images independently, followed by the cell associa-
tion between consecutive frames. While this approach can be easily implemented for cell tracking, 
such a method is prone to tracking error because it relies entirely on the segmentation efficiency. 
The second approach involves segmenting the cell in the first frame and tracking these cells in the 
following image sequence. However, this approach does not naturally handle cell division events135. 
We designed our algorithm based on the first approach, because our segmentation method pro-
duced robust and accurate results. Our cell linking algorithm is a simplified version, similar to the 
one already described by Al-Kofahi et al.135. Briefly, all possible associations of a cell on one frame 
 
Figure 3.3: Schematic description of the feedback loop imple-
mented in the segmentation algorithm. 
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to the next frame are weighted using a “matching function. Then if the number of cells over two 
frames remains constant, mathematically, the problem can be summarized as follows. For a number  
 
of N cells at a time t and N cells at a time t+1, and an N x N matrix “S” containing the matching index 
value for one cell to its corresponding cell, we should find the overall minimum matching value while 
assigning each cell at time t to exactly one cell at time t+1 (Figure 3.5B).  
Figure 3.4: Representative image sequences, illustrating the bright field images (1), the corresponding segmented images
(2) and the overlay of the two (3). Examples of segmentation of cells that (A) remained quiescent, (B) differentiated into 
MK, (C) died, (D) proliferated. 
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We found the best matching assignment between cells in matrix S by applying the Hungarian algo-
rithm144. However, when a cell has divided, there are different cell numbers in adjacent frames and  
 
the Hungarian method cannot be applied directly, as it requires a square matrix (i.e., for this algo-
rithm one cell at time t cannot be matched to 2 cells at time t+1). To solve this problem, we created 
a division matrix “D”, where we placed composite cells made from a hypothetical pair daughters 
(i.e., two cells at time t+1 are merged together to create a new one) (Figure 3.5C). Once the best 
match in matrix D is found, the rest of the assignment matching is performed in the square matrix 
S (Figure 3.5A) using the Hungarian algorithm.  
The matching values for matrix S are evaluated through a function ???? that calculates an assignment 
value of a cell i at time t (???) and its corresponding cell j at time t+1 (?????). For each cell i at time t, 
we find its centroid in terms of pixel position (??? = (???  ,???)) and its area ???. We then model the 
matching index as follows:  
???? =
??(?) ?  ?? + ??(?) ? (1?  ??)
2  
Where ??(?) = ???
??????? ?
?????
  ??? ??(?) =  ???
??????? ?
?????
 represent respectively the absolute difference 
of area and the distance between ??? and ?????. Anorm and Xnorm are local normalization factors (de-
fined for each frame) so that ??(?) ??? ??(?)  ? 1.  ?? represents the weight factor between the 
area and the distance values.  
Similarly, for the matching index for matrix D, one cell ??? should be assigned to a pair of cells ????? 
and ?????. These cells are merged together to form one composite cell (??????) so that ??? is assigned 
Figure 3.5: Cell linking through frames. (A)
Representation of the two matrices, used for
the cell-cell association with division (D) or
without division (S). Each position of matri-
ces (i,j) represents the index value of a cell at 
time t (i) to another cell at time t+1 (j). The 
matrix is filled by calculating matching index 
values with cost functions described in the 
results section. The best matching assign-
ment among all possible associations is 
found by using the Hungarian algorithm. (B)
Example of possible tracks between cells 
without divisions. (C) If a division occurred, 
an additional step is performed so that each 
cell at time t finds only one correspondence 
at time t=t+1. All possible daughter cell pairs 
are therefore virtually merged together (as
illustrated in schemes on the right) and for 
each of them a matching index value is cal-
culated and placed in the matrix D.  
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to only one cell. We then calculated the centroid of ?????? that is the mean value of the cells’ centroid: 
?????? =
?
? (??
??? + ????? ,????? + ?????)), and similarly for the area ?????? =
?
? (??
??? + ????? ,????? +
?????)). We then model the matching index as follows:  
????? =
??(?) ?  ?? + ??(?) ? (1?  ??)
2  
Where ??(?) = ???
???????? ?
?????
  ??? ??(?) =  ???
???????? ?
?????
 .  ?? represents the weight factor between the 
area and the distance during a division.  
A representative example of cell-cell association is shown in Figure 3.6 and in Supplementary Figure 
S3.1. When a cell was wrongly associated to another cell or daughter cells in the next frame, we 
considered it an error in tracking an event. We found 8.3% error in image sequences (or 0.04 errors 
per 100 frames).  
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Figure 3.6: Automatic tracking with generation of lineage trees. (A) Representative example of lineage tracking of a proliferating
single HSC. Each cell is labelled with 0 and 1 and the number of digits represents the generation. For example, the first seeded
mother cell (generation 0) is labeled with a “0”. The first daughter cells (generation 1) will have two digits “00 and 01”, daughter
cells from cells “00” will be “000 and 001”. (B) Same image sequence of (A) shown in regard to the cell displacement (centroid
position). Tracks are colored according to cellular size. From small to large size: red, yellow, green, light blue, dark blue and purple.
(C) Corresponding lineage tree from (A). (D) Zoom on tracks during a division. The difference of colors shows that daughter cells are
smaller than the mother cell. 
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3.3.5 HSCs’ analysis in the presence of drugs 
Here we report an experimental strategy to analyze automatically the effects of drugs on HSCs. As 
a proof of concept, we focused on several readout parameters: the proliferation kinetics (average 
number of cells per groove, time spent prior to first division and the proportion of asynchronous 
divisions), cell viability, differentiation into MK, cell size and the mean cell displacement before the 
first division. Asynchronous divisions are defined as those where one daughter cell divides 6h before 
its sister cell does. For this experiment, we selected three drugs that affect fatty acid oxidation (FAO) 
of HSCs. FAO occurs in mitochondria and in peroxisomes145, and was found to be an interesting 
target that allows modulation of HSC fate. Indeed, it has been established that mitochondrial FAO 
(mitoFAO) stimulation via activation of PPAR-? promotes asymmetric divisions in HSCs51. However, 
FAO modulation in HSCs was never characterized during in vitro culture. Thus, we used GW501516, 
a PPAR-? agonist used in 2012 by Ito et al.51, to increase the number of asymmetric divisions in HSCs; 
GSK0660, a PPAR-? antagonist that negatively regulates FAO; and finally we treated HSCs with 
10,12-tricosadiynoic acid (TDYA), a specific inhibitor of peroxisomal FAO (peroxFAO)146. TDYA irre-
versibly blocks the first enzyme of peroxFAO, namely ACOX1. As illustrated in Figure 3.7, we ob-
served notable changes in our readout parameters upon treatment with drugs, as compared to ba-
sal medium (control). While the doubling time was 83h for non-treated cells, PPAR-? antagonist and 
PPAR-? agonist markedly decreased the doubling time to 56h and 53h, respectively (Figure 3.7A). 
TDYA treatment had a mild effect on the average number of cells per groove, as compared to the 
basal medium. These results may be explained by the fact that the number of MK cells is higher in 
the basal and TDYA supplemented media, and because these cells do not proliferate they lowered 
the overall proliferation kinetics (Figure 3.7F). This hypothesis is confirmed by analysis of the cumu-
lative histogram of the time spent by a cell prior to the first division (Figure 3.7B). Here, PPAR-? 
antagonist and PPAR-?  agonist-treated cells showed only a slight increase in division time (respec-
tively 1h and 4h) in comparison to basal medium conditions. Intriguingly, TDYA seems to affect the 
time of first and second divisions significantly, as compared to the basal medium (+7h and +13h, 
respectively) (Figure 3.7B-C). This is an interesting result, because HSCs are marked by slower cell 
cycling, as compared to progenitor cells14. In addition, HSCs treated with TDYA demonstrated a sig-
nificant increase in the proportion of asynchronous cell divisions (58%) as compared to HSCs in the 
basal medium (33%), which suggests that TDYA increased the number of asymmetric divisions (Fig-
ure 3.7D).  
As mentioned previously, PPAR-? agonist was shown to promote asymmetric divisions in HSCs51. In 
agreement with this observation, we found an increase in the number of asynchronous divisions 
(48%) upon PPAR-? agonist treatment (Figure 3.7D). However, PPAR-? antagonist had no effect on 
asynchronous division, as compared to control. While the viability seems not to be affected by PPAR-
? agonist and TDYA, the presence of PPAR-? antagonist increased the number of cell death events 
(Figure 3.7E). Overall, TDYA effect on HSCs is intriguing. Interestingly, Zeng et al.147 found that the 
inhibition of peroxFAO in liver cells activates mitoFAO. In homeostatic conditions, PeroxFAO pro-
duces acetyl-CoA that can be transformed into malonyl-CoA148, which in turn negatively regulates 
mitoFAO through inhibition of CPT-1A147. In the presence of TDYA, peroxFAO is blocked, which might 
decrease the cellular malonyl-CoA concentration and, consequently, activate mitoFAO146,147. This 
could explain the higher proportion of asynchronous divisions observed with TDYA treatment. This 
hypothesis needs to be interpreted with caution, and the observation made in liver cells must first 
be verified in HSCs before final conclusion.  
In certain circumstances, cell size and mean displacement could be meaningful readout parameters. 
Typically, when the substrate on which cells are grown is modified with bioactive molecules (for 
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example, niche-like proteins), the cells might adhere to this substrate differently and, as a conse-
quence, would change their movement speed. Their size could also change73,149. Therefore, we com-
pared cell sizes and mean cell displacements prior to the first division between the three drug treat-
ment conditions (Figure 3.7G-H). We found a significant decrease in cell size in all conditions, as 
compared to the basal medium. Also, cells subjected to TDYA treatment moved slightly more than 
in the control conditions. These preliminary results illustrate the potential of the cell lineage tracking 
algorithm, when it is used in combination with the micro-groove array-based cell culture platform. 
 
3.4 Conclusions 
In the field of HSCs, scientists still face a lack of high-throughput tools that allow studying single 
HSCs and their lineages. In this study, we presented a new algorithm for lineage tracking and prog-
eny analysis. Tracking was performed using bright field microscopy in order to minimize phototoxi-
city during time-lapse imaging. We showed that the algorithm can efficiently detect and track HSCs 
and also demonstrated its applicability to the drug screening experiments. The implementation of 
the algorithm to this task demonstrated the high accuracy of cell lineage tracking. In line with Ito et 
al.51, we found that PPAR-? agonist (GW501516) increases the number of asymmetric divisions. 
Figure 3.7: Analysis of HSCs cultured in the presence of various drugs. (A) Average proliferation rates measured for single live cells
in each condition and (B-C) Cumulative histogram of time spent prior to first or second division for indicated population. (Basal n= 
48; GW501516, n=49; GSK0660, n=23; TDYA, n=43; dead cells excluded). (D) Frequency of asynchronous divisions per condition. (E) 
Viability. (F) Frequency of differentiation into MK events. (G) Mean cell area. Numbers show average and SEM. Statistical analysis
was performed using one-way Anova followed by Bonferroni’s test. ****p< 0.0001, ***p< 0.001, **p< 0.01, *p< 0.05 
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TDYA, a drug specifically inhibiting the peroxisomal FAO, surprisingly increased the number of asyn-
chronous divisions in HSCs, besides increasing the duration of time spent prior to the first division. 
These preliminary findings raise the intriguing possibility that peroxisomal FAO might have an im-
portant role in governing the HSC fate decisions. Overall, we think that this study lays the ground-
work for future high-throughput analysis of HSCs in vitro.  
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Figure S 3.1: Image sequences in bright field (A) with corresponding segmentation (B), overlay of the two (C) and
lineage tree (D). 
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 Monitoring of mitochondrial mass 
of HSCs in culture 
Abstract  
Currently, the identities of the hematopoietic stem cells (HSCs) and progenitors cells have not yet been defined in in 
vitro culture as the result of a lack of markers that would correlate their phenotypes to their fate. Previously, we devel-
oped a state-of-the art single cell tracking platform that enables the imaging of single cells and their lineages during 
long-term experiments (up to 5 days) in vitro and simultaneous study of the individual cell division kinetics. We applied 
these techniques to study the purified but still heterogeneous long-term murine hematopoietic stem cells (LT-HSCs) 
defined as Lin- ckit+ Sca1+ CD150+ CD48- CD34-. We measured the mitochondrial mass in single LT-HSCs and its distri-
bution between their lineages and found that the mitochondrial mass in LT-HSC progeny correlates with the LT-HSC 
fate. Moreover, our results indicated that mitochondria are distributed asymmetrically in the daughter cells that un-
dergo temporally asynchronous divisions (with a time difference of at least 24 h between the corresponding divisions). 
In contrast, a more symmetrical mitochondrial mass distribution was observed in the cells that undergo temporally 
synchronous divisions. This observation signifies the existence of a mechanism that selectively distributes mitochondria 
during asymmetric divisions in LT-HSCs, which is likely linked to the LT-HSC fate choice. 
4.1 Introduction 
Currently, the in vitro expansion of hematopoietic stem cells (HSCs) is confounded by the rapid loss 
of their stem cell function. One of the main reasons behind this is an inability to provide the correct 
biological signals to HSCs during their culture outside the natural niche. Depending on the nature of 
signaling, HSCs are forced to undertake various cell fate decisions including self-renewal, hemato-
poietic lineage commitment, quiescence or apoptosis150,151. In practice, HSCs rapidly differentiate 
during in vitro culture, which limits their use in clinical therapy152. In order to understand the mech-
anisms underlying the HSCs fate choices, it is essential to track the lineages of individual stem 
cells62,153,130.  
Here, we used a platform that enables tracking of single HSC lineages. First, by characterizing HSCs 
behavior on the platform, we demonstrated that it permits the study of HSCs during the culture in 
serum-free medium. Importantly, the high throughput nature of our platform allowed observation 
of 614 individual cells in just 3 experiments. Secondly, following the recent evidence of mitochon-
drial involvement in HSC fate decision128,154, we used the platform to monitor mitochondrial mass 
in cell lineages to better understand its connection with HSC fate. It was demonstrated that HSCs 
rely more on glycolysis for ATP production than mitochondrial oxidative phosphorylation 
(OXPHOS)28,155. Consistent with these results, Vannini et al. showed that functional HSCs are marked 
by low mitochondrial activity and mass while committed progenitors, in contrast, preferentially pro-
duced ATP by mitochondrial OXPHOS and have a higher mitochondrial mass156,50. These observa-
tions have been recently challenged by Almeida et al. who demonstrated contradictory results (i.e. 
higher mitochondrial mass in HSCs in comparison to committed progenitors cells)157. This experi-
ment was, however, performed on a highly heterogeneous populations of hematopoietic cells (Lin-
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ckit+CD48-) that also contains progenitor cells14. Nevertheless, although the mitochondrial metab-
olism is currently a major focus of research in the field of HSC, the mechanistic link between mito-
chondria and the HSC fate is still poorly defined158. To characterize how mitochondrial mass is cor-
related to HSC fate in vitro, we used the micro-groove platform to quantify the mitochondrial mass 
in individual LT-HSCs and further the distribution of mitochondria in corresponding single cell line-
ages.  
Interestingly, our results showed that mitochondrial mass evolution in lineages over time is different 
regardless of whether the HSCs had differentiated, remained quiescent or proliferated.  
In addition, we found a striking asymmetric distribution of mitochondria between daughter cell pairs 
that had divided asynchronously (i.e., when one daughter cell divides 24 h before its sister). As this 
phenomenon was proposed to be correlated with asymmetric division (AD) of HSCs129, our results 
support that mitochondria is tightly linked with AD and that a distribution mechanism of mitochon-
dria during AD might take place in HSCs. 
4.2 Materials and Methods 
4.2.1 Isolation of LT-HSCs 
Hematopoietic stem and progenitor cells were isolated from crushed bone marrow of 8-16 weeks 
C57Bl/6 mice or r26-mitoEGFP mice. Erythroid cells were eliminated by incubation with red blood 
cell lysis buffer (Biolegend). Lineage depletion (CD3, B220, Ter-119, CD11, Gr-1) was performed us-
ing the Hematopoietic Progenitor Cell Enrichment set (BD Biosciences). Cells were stained with SAV-
PO (Life Technologies), Kit-PE-CY7 (2B8, BioLegend), Sca1-PE (D7, BioLegend), CD150-BV784 (TC15-
12F12.2, BioLegend), CD48-PB (GM48-1, BioLegend), CD34-eF660 (RAM34), eBioscience). LT-HSCs 
?????????????????????-????????????????????????????????????????????????????-HSCs as LKS CD150+ 
CD34+ and MPP as LKS CD150- CD34+. After extraction, cells were seeded on platforms and time-
lapse microscopy was performed. HSCs were cultured in “Basal” medium defined as a serum free 
medium StemlineII (Sigma-Aldrich, St. Louis, USA) supplemented with 100ng/ml stem cell factor 
(SCF) and 2ng/ml Flt-3 ligand (R&D Systems, Minneapolis, USA) or in the differentiation-inducing 
medium, composed of the basal medium with the addition of 20ng/ml Il-3 and 100ng/ml Il-6 (R&D 
Systems, Minneapolis, USA). 
4.2.2 Single HSC trapping and lineage tracking 
Micro-groove arrays were fabricated and used as described (Trachsel et al., Submitted). HSCs were 
cultured in basal or differentiation media for 70h and bright field images were acquired every 30min 
or 1h on a Zeiss Observer microscope. 
4.2.3 Mitochondrial mass measurement  
For the live cell mitochondrial mass measurements, freshly isolated LT-HSCs from R26-Mito-eGFP, 
were seeded on the platform and visited every 24h during 5 days. Mitochondrial mass was quanti-
fied as the intensity-thresholded area of mito-eGFP signal. Images were processed in imageJ.  
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4.2.4 Colony Formation 
Lin- cells (1000 per experiment) were cultured for 1.5 days on platforms or standard 96 well plate. 
Then cells were cultured in MethoCult GF (M3434, Stem Cell Technologies) and colony-forming cell 
mass was scored at day 8.  
4.2.5 Statistical Analysis 
Pairwise comparisons were performed using Student’s t test. For multi-comparaisons, one-way 
Anova followed by Bonferroni’s test was used. 
4.3 Results and Discussion 
4.3.1 Characterization of HSCs cultured on a micro-groove platform for lineage tracking 
To study single HSCs and their subsequent progeny, we used a previously developed tracking plat-
form (Figure 4.1A) (Trachsel et al., Submitted). The platform is briefly composed of an array of 
grooves that are closed after cell seeding with a permeable polyethylene glycol (PEG) hydrogel. The 
platform is designed in such a way that the single cells seeded into the grooves are encapsulated 
and forced to grow and move in a line. Such design does not allow cells to interchange their relative 
positions. Hence, the platform enables precise tracking of single cell progeny by optical microscopy 
even if the time elapsed between two consecutive image acquisitions is close to a full cell cycle 
(Figure 4.1B-C). We first characterized the fate of LT-HSCs (Lin- ckit+ Sca1+ CD150+ CD48- CD34-) 
cultured on the platform for 72h in three independent experiments. In line with previous studies, 
we found that the LT-HSC population is heterogeneous111. Indeed, 56.6% ± 11.1% of cells underwent 
proliferation, 13.2% ± 2.8% differentiated into very big cells (that were considered to be megakar-
yocytes111,159), 11.8% ± 4.1% never divided (a fate termed “quiescence”) and 18.4 ± 13.2% died. We 
next assessed division kinetics of the LT-HSCs on the platform (n=100) and compared it to the con-
trol conditions (n=248) when cells were cultured in PEG-microwells149. The principal difference be-
tween the culture in PEG-microwells and micro-groove platform is that in PEG-microwells, the cells 
are not encapsulated and can move freely in all directions whereas the HSCs’ movement in the mi-
cro-grooves is bidirectional. Importantly, the spatial confinement of HSCs, which is achieved when 
they are fully embedded in a hydrogel, was shown to change their proliferative behavior160. How-
ever, in our micro-groove encapsulation conditions, we observed remarkable similarity in the cell 
growth rates when compared to open PEG-microwells (Figure 4.1J). This demonstrates that the HSC 
proliferation kinetics are not affected. We next assessed the HSC response to supplementation of 
Il-3 and IL-6 cytokines, which are known to activate their cell cycling42. As expected, the cells prolif-
erated faster in comparison to basal medium conditions (Figure 4.1K). The cell number doubling 
time of 55 h in the basal medium (ctrl, n=106) decreased to 37 h in IL3, IL6-induced differentiation 
conditions (n=45). We further assessed whether the culture in the platform could influence the col-
ony forming potential of hematopoietic cells when compared to a culture in standard plastic well 
plate (Figure 4.1L). The statistical analysis revealed no significant difference between the two con-
ditions, both for the colonies derived from the more committed progenitors such as megakaryocyte 
and erythroid colonies (MK/E), granulocyte and/or macrophage colonies (G, M, GM) and the highly 
proliferative colonies derived from the most primitive cells (GEMM). Taken together, these results 
suggest that the HSCs cultured on the tracking platform have similar proliferation kinetics and po-
tential than the control culture in PEG or plastic well. Therefore, the platform is suitable for studying 
HSCs.  
Monitoring of mitochondrial mass of HSCs in culture 
62 
4.3.2 Mitochondrial mass measurement in LT-HSCs and their lineages 
It is well established that mitochondria play a role in the homeostasis of HSCs161,162. While HSCs have 
low mitochondrial mass and rely on glycolysis for energy generation, progenitor cells rely on mito-
chondrial oxidative phosphorylation50. However, the amount of mitochondria in functional HSCs has 
been recently questioned due to the limitation of the dye-dependent methods used to measure 
mitochondrial mass. However, it has indeed been shown that the efflux of the dye from mitochon-
dria increases in primitive HSC population, which might lead to erroneous conclusion157. For this 
reason, we employed a genetically modified mouse line (R26-mito-eGFP) that ubiquitously ex-
presses enhanced green fluorescent protein (eGFP) in the mitochondria of all cells (Figure 4.2E). We 
were therefore able to measure the mitochondrial mass in single LT-HSCs seeded on the platform 
(n=174) and in all subsequent cells derived from them (cumulative total number of cells, n=1547) in 
an accurate manner without the use of fluorescent dyes. The mitochondrial mass of each cell was 
mapped on its respective lineage tree (Figure 4.2C-D), thus providing a correlation between the ob-
served mitochondrial mass phenotype and the proliferation kinetics in single LT-HSCs and their prog-
eny. It is to be noted that in order to observe whether mitochondrial monitoring affect cells, we 
compared the proliferation kinetics between the HSCs with mitochondrial mass acquirements (i.e. 
exposed to fluorescent light) and cells without and did not find any significant difference (Figure 
4.2F-H). 
4.3.3 Mitochondria are asymmetrically distributed in sister cells after divisions 
We cultured single LT-HSCs until they underwent at least two divisions. This allowed us to define 
daughter and cousin cell pairs according to their lineages. Daughter cells are pairs of sister cells of 
the first generation (derived from the initially seeded mother cell). Cousins cells are the pairs of 
sister cells of the second generation when each of them is derived from the same daughter cell of 
the first generation (Figure 4.2C). We wanted to find out whether mitochondrial mass distribution 
is correlated to the type of division undergone by a single stem cell. We classified the division types 
as asymmetric divisions (AD) or symmetric divisions (SD)162,163. AD is a process during which a 
mother stem cell produces a pair of sister cells that have different cellular fates, for example, when 
one cell preserves a stem cell function and another becomes a committed hematopoietic cell. In 
contrast, SD will produce daughter cells with equal fate127. When the mother cells divide asymmet-
rically, its daughter cells will have certain different phenotypical aspects. Therefore, we decided to 
assess whether the sister cells produced by an AD would have a higher difference in its mitochon-
drial mass when compared to the sister cells produced by a SD. We defined the difference in mito-
chondrial mass between the two sister  
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cells or between two pairs of cousin cells as mitochondrial asymmetry (Figure 4.2E). This difference 
is calculated by subtracting the eGFP signal intensity of one cell from the corresponding value of 
another as shown by the black arrows in Figure 4.2E and in the formula below: 
????????? ?? ???????? ????? =  |?? ? ??| 
where ?? ??? ?? are the values corresponding to two daughter cells. In order to compare two pairs 
of cousin cells, the average value for each pair of sister cells is taken as follows: 
????????? ?? ?????? ???? ????? =  ??? + ??2 ?  
?? + ??
2 ? 
where ?? ??? ?? are values of the first pair of sister cells and ?? ??? ?? are values of the second pair 
of sister cells. 
One of the key properties of HSCs is their slower cycling rate in comparison to the progenitors 
cells164–166. Therefore, we used this parameter to detect the AD in vitro. The difference in the time 
of division between daughter cells would indicate different cellular fate and, consequently, can be 
used to detect AD129,138. If the difference in time between two daughter cells divisions was 24 h or 
more, the division was defined as asynchronous (Figure 4.3D). Otherwise, the division was consid-
ered as synchronous129. In addition, if only one of the daughter cells had divided, we also considered 
this as an asynchronous divisions. We then grouped cell lineages according to the type of division 
(synchronous or asynchronous) and compared the mitochondrial mass distribution asymmetry be-
tween either daughter cells or pairs of cousin cells. Strikingly, the daughter cells that underwent an 
asynchronous division displayed a significantly higher mitochondrial mass distribution asymmetry 
as compared to the synchronous daughter cells (Figure 4.3A). Interestingly, the same pattern was 
observed when the mitochondrial mass distribution was analyzed for pairs of cousin cells that were 
themselves produced by asynchronous or synchronous divisions (Figure 4.3A). Thus, it could be hy-
pothesized that the HSC fate decision occurs during the first division and that the subsequent pairs 
of cousin cells inherit the fate of the corresponding daughter cells. But this hypothesis remains to 
be confirmed. Our results also imply that the mitochondria are not randomly distributed during AD 
and that some mechanism of selective distribution of mitochondria between daughter cells exists 
for dividing HSCs. Interestingly, such a phenomenon has been observed in dividing budding yeast153 
and in germ line cells in Acricotopus167. Moreover, a remarkable experiment performed by Katajisto 
 
Figure 4.1: Platform for single-cell trapping with multi-lineage tracking. (A) The platform is made of an array of grooves on the glass 
coverslips. (B) Single cells sediment in the groove by gravitation and are encapsulated by covering with a permeable lid. (C) Tracking 
is performed by acquiring time-lapse bright field microscopy images. Cells are forced to grow in a line within the corresponding 
groove. (D) Representative example of HSCs, cultured on the platform. Black arrows indicate cells at t=0, 24, 48 and 72 h. (E-I) Single 
cell analysis revealed significant heterogeneity in the HSC compartment. The quantification of cell fate choices observed in three 
independent experiments with a total number of 614 single cells. Percentages are given as average ± SD. (J) Average number per 
groove of progeny cells derived from single HSCs observed at the end of the experiment when cultured in polyethylene glycol (PEG) 
microwell – or in the tracking platform (blue line, n=248 and red line, n=100, respectively). Dead cells were excluded. (K) Average 
number per groove of progeny cells derived from single HSCs cultured in basal or differentiation medium (blue line, n=106 and red 
line, n=45, respectively). Dead cells were excluded. (L) The percentage of colony types (G/M/GM, green; Mk/E, light green; GEMM, 
red), measured by hematopoietic colony-forming assay at day 10 from 1000 Lin- cells, cultured 1.5 days on the platform or plastic 
well plate. (CFU-)G: Colony forming unit-granulocyte; (CFU-)M: Colony forming unit-macrophage; (CFU-)GM: Colony forming unit-
granulocyte, macrophage; (CFU-)GEMM. Percentages are given as average ± SD from three independent experiments. N.S (Non-
significant) in Student’s t test. 
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et al. showed that aged mitochondria are asymmetrically distributed after a division of human mam-
mary stem-like cells and that cells that received fewer old mitochondria remained as stems168.  
4.3.4 Mitochondrial mass distribution asymmetry in different cell generations 
To identify if the mitochondrial mass asymmetry in sister cells correlates to the number of divisions 
and the time of division, we analyzed the mitochondrial mass distribution asymmetry depending on 
the time spent until the division. Our analysis revealed that the mitochondrial mass asymmetry in 
the first generation of cell increases with the time spent until the division (Figure 4.3B). This result 
indicates that mother cells that divide later (i.e. remaining for a longer time in a dormant state) 
produce more asymmetric daughter cells. This observation is interesting as it was suggested that 
functional HSCs have slower cycling rates when compared to progenitor cells166. A higher mitochon-
drial mass distribution asymmetry in daughter cells derived from slower cycling mother cells cor-
roborates this idea. 
In contrast to what we observed in first generation daughter cells, the mitochondrial mass distribu-
tion asymmetry in the second generation remains independent on the time spent until the division 
and is significantly lower than the asymmetry in first generation daughter cells (Figure 4.3B). This 
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result suggests that asymmetric divisions are more likely to occur during the first divisions in our in 
vitro system and are probably less common during the second divisions.  
Figure 4.2: Single cell lineage tracking and mitochondrial mass measurement. (A-B) Representative images from time-lapse
microscopy showing single LT-HSCs proliferating over 5 days. (B) Corresponding cells in eGFP (mitochondria) channel. (C) The
corresponding lineage tree of (A). The scheme demonstrates how sister cell pairs are defined for mitochondrial asymmetry 
analysis. (D) Mitochondrial mass measurements from the eGFP signal of cells in (A). Black arrows indicate the difference of
mitochondrial mass between sister cell pairs. (E) Illustration of mitochondrial asymmetry. (F-H) LT-HSC proliferation kinetics
with mitochondrial mass measurement (fluorescence excitation exposure) (?, red line, n=47 cells) or without mitochondrial 
mass measurement (ctrl, blue line n=70 cells). Dead cells are excluded. (F) Average cell number per groove. (G) Cumulative 
histogram of the time spent until the first division. At 50% of divided cells, there is a difference of 5 h between conditions.
(H) The cumulative histogram of time spent until second division. At 50% of divided cells, there is a difference of 6 h between 
conditions. 
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4.3.5 Mitochondrial mass distribution asymmetry, correlated to mitochondrial mass of the 
mother cell 
Regression analysis was used to measure the correlation between the mitochondrial mass of mother 
cells and the asymmetry of mitochondrial mass distribution between their respective daughter cells. 
Since HSCs are marked by low mitochondrial mass50, we hypothesized that mother cells with low 
mitochondrial mass would more likely undergo an asymmetric division169. However, no such corre-
lation was found (Figure 4.3C), suggesting that the mitochondrial mass of mother cell on its own is 
not sufficient enough to predict the asymmetry of the mitochondrial mass distribution between 
daughter cells. 
4.3.6 Initial mitochondrial mass marks LT-HSCs fate 
Finally, we grouped single LT-HSCs and their corresponding lineages according to the following 
mother cell fate outcomes observed at the end of the culture: quiescence; proliferation limited to 
one division; proliferation (more than one division); direct differentiation into megakaryocyte (MK); 
symmetric differentiation “SD MK” (resulting in two daughters that both gave rise to MK); or asym-
metric differentiation “AD MK” (resulting in one daughter that gave rise to MK and one that re-
mained small).  
We then observed how the mean mitochondrial mass of each of these mentioned groups fluctuated 
during culture. Interestingly, the mean mitochondrial mass is highly different between groups (Fig-
ure 4.3E). Overall, the megakaryocytic-fated cells’ mean mitochondrial mass show a notable in-
crease over time in contrast to other groups whose mean mitochondrial mass remained more con-
stant (Figure 4.3E). Moreover, at the beginning of culture, the quiescent cells have significantly 
lower mitochondrial mass (0.7±0.1) in comparison to other groups (MK=1.1±0.4, AD MK=1±0.2, Pro-
liferation=1±0.2) (Figure 4.3F). The observed lower mitochondrial mass in these cells are in line with 
other groups50,156.  
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4.4 Conclusion 
The first aim of the present study was to characterize the LT-HSC behavior when cultured on our 
micro-groove lineage tracking platform. We successfully demonstrated that the platform is suitable 
for studying HSCs by demonstrating its similarity in various cellular parameters, including cell fate, 
proliferation kinetics and cell functionality, between the cells cultured on the platform and the cells 
cultured in standard conditions. We then used the platform to track the mitochondrial mass in HSCs 
throughout a period of 5 days. Collectively, our experiments revealed the existence of a specific 
distribution mechanism that segregates mitochondria, preferentially to one of the daughter cells, 
during an asymmetric division. These results further support the idea that the HSC fate is tethered 
to mitochondria161. This work encourages further studies that would assess mitochondrial mass dis-
tribution asymmetry in the presence of molecules known to increase the frequency of asymmetric 
divisions in HSCs51 or, in contrary, direct HSCs toward symmetric commitment42. Additional investi-
gation should also be carried out to distinguish whether the mitochondrial mass distribution during 
AD is also linked to the difference in the metabolic activity of these mitochondria. 
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Figure 4.3: Mitochondrial mass analysis of 174 individual LT-HSCs. (A) Mitochondrial asymmetry in daughter cells or cousin cells
correlated to synchrony. (B) Mitochondrial mass distribution in sister cells of the first (black) or second (red) generation. (A–B) The
inset demonstrates which cells (in green and blue) are used for asymmetry calculation. Statistical analysis is performed by one-way 
Anova with Bonferonni post-hoc analysis: *p<0.05, **p<0.01, ***p<0.001. The asymmetry index for sister cells is calculated as the
absolute difference of mitochondrial mass (|?? ? ??|) where ?? ??? ?? represent the sister cell values. Similarly, the difference of
mitochondrial mass between cousin cells was taken as (??????? ?  
?????
? ?) where ?? ??? ?? are the values of two sister cells that are 
both the cousins of cells with values ?? ??? ??. (C) Correlation between mitochondrial mass of mother cells and the asymmetry of 
mitochondrial mass distribution between their respective daughter cells. (D) Scheme illustrating an asynchronous division (E) Mito-
chondrial mass evolution from day 0 to day 5 depending on the cell fate: no division (quiescence, brown line), one division (pink 
line), symmetric differentiation into megakaryocyte (SD MK), differentiation into megakaryocyte without division (MK), asymmetric 
differentiation into megakaryocyte (AD MK, one or more division) and proliferation (more than one division). Error bar shows stand-
ard deviation. (F) Mitochondrial mass on day 0, depending on subsequently defined cell fate. 
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Abstract
Hematopoietic stem cells (HSCs) maintain their own population and produce committed daughter cells for the life-long 
production of all mature blood cells. Under homeostasis, HSCs in the native niche are believed to achieve this dual role 
by undergoing a process called asymmetric cell division (ACD), whereby one daughter cell maintains stem cell potential 
while the other differentiates to give rise to various blood cell lineages. Lack of critical instructive signals in the in vitro 
environment results in rapid loss of functional HSCs, making it extremely challenging to study self-renewal and ACD in 
a dish. Here, we explored the possibility to “pre-instruct” fate in activated HSCs directly in their in vivo niche in order to 
assess the fate choices for dividing HSCs in vitro in a cell-intrinsic manner. To this end, we pushed HSCs out of their 
dormancy by Interferon-????????????????????????????????????????????????????????????????????????????????????????????????????
followed by multi gene and protein expression analysis at the single cell level. We demonstrate that IFNa treatment 
significantly increases the proportion of asynchronous divisions of HSC daughters, indicating a possible involvement of 
asymmetric cell divisions. The gene expression analysis of PDCs revealed a set of 12 asymmetrically expressed genes. 
We then confirmed these results by analyzing the asymmetric expression at the protein level, where we found three 
candidates to be highly asymmetric, namely, Glut1, JAM3 and HK2. Preliminary functional analysis by colony forming 
assays revealed that the combination of Glut1 and JAM3 allows reliable discrimination of a differentiated daughter HSC 
from a self-renewing one during an ACD.  
5.1 Introduction 
The maintenance of a hematopoietic stem cell (HSC) pool and a concomitant production of commit-
ted daughter cells for life long generation of mature blood cells is achieved by a well-orchestrated 
balance of HSC fate choices in vivo. This regulation restricts uncontrolled stem cell expansion or 
differentiation that could be detrimental for the organism. Asymmetric cell division (ACD) is an in-
triguing strategy that allows for both the maintenance of stem cell number as well as the production 
of differentiated progeny at the same time170. Previous studies on paired daughter cell (PDC) have 
revealed different colony forming potential171,172 and in vivo reconstitution ability38,173 in sister cells, 
suggesting the occurrence of ACD in HSCs. However, most in vitro methods lack critical instructive 
signals of the in vivo niche. Therefore, it is currently not possible to study niche-instructed HSC fate 
choices, especially ACD, in a dish. Here, we explore the possibility to ‘pre-instruct’ HSCs directly in 
the in vivo niche in order to assess the fate choices of dividing HSCs in a cell-intrinsic manner.  
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To this end, we used Interferon-??????????????????????????????? ?????????????????????????????????
in their native environment174. Intriguingly, the IFNa activated HSCs demonstrated a significant in-
crease in the proportion of asynchronous cell divisions, suggesting the execution of ACD. Single cell 
gene expression analysis on PDCs revealed an asymmetric gene set and showed significantly higher 
“asymmetry index” values for IFNa activated HSCs. High resolution confocal imaging confirmed in-
creased asymmetry for the three selected markers in IFNa treated HSCs. Furthermore, we charac-
terized the expression of one of the markers, namely, Glucose transporter 1 (Glut1). In line with 
previous studies175, the flow cytometry analysis revealed lower Glut1 expression in phenotypic 
HSCs. Using co-staining and functional assays, we found that post cell-division, daughter cell with 
low Glut1 and high JAM3 expression show a more primitive phenotype. Collectively, we established 
IFN-based activation as a useful model to understand the molecular mechanisms mediating ACD in 
murine HSCs and identified an asymmetric gene set that provides a first glimpse of the molecular 
players involved in ACD. 
5.2 Materials and methods 
5.2.1 In vivo activation of HSCs 
HSCs were activated to exit dormancy by interferon-alpha (IFNa) treatment following published pro-
tocols50,174. Briefly, subcutaneous injections in C57Bl/6J mice were carried out with 10,000U of IFNa 
(R&D systems) 48 and 24 hours prior to bone marrow extraction. Control mice were injected with 
an equivalent volume of the vehicle (PBS + 0.1% BSA). 
5.2.2 Antibodies 
The following antibodies were used: cKit-PeCy7 (2B8, Biolegend), Sca1-APC (D7, Biolegend), CD150-
PeCy5 (TC-15-12F12.2, Biolegend), CD48-PB (GM48-1, Biolegend), CD34-FITC (RAM34, eBiosci-
ences), SAV-PO (life technologies). A mixture of biotinylated mAbs against CD3, CD11b, 
CD45R/B220, Ly-6G, Ly-6C and TER-119 was used as lineage depletion cocktail (BD Biosciences). 
5.2.3 Cell cycle analysis 
FACS sorted HSCs were fixed and permeabilized using Cytofix/Cytoperm plus kit (BD Biosciences), 
according to the manufacturer instruction. Cells were then stained overnight with Ki67 FITC (BD 
Biosciences) at 4°C, and 10 minutes with Hoechst 33342 (Invitrogen). Stained cells were run on a BD 
LSRII for cell cycle analysis. 
5.2.4 Micro-groove array platform fabrication 
Micro-groove arrays were fabricated and used as described (Trachsel et al., Submitted). Briefly, the 
platform is composed of two parts: one containing the groove array (bottom) and one used as a lid 
to close the groove (top). The lid covalently reacts with the bottom part, therefore cells seeded on 
the groove array are encapsulated allowing an unambiguous tracking of cells and their progeny. The 
bottom part is made in poly(2-hydroxyethyl methacrylate)-trimethylolpropane trimethacrylate co-
polymer (pHEMA-TMPTMA) and the permeable lid in self-assembling polyethylene glycol (PEG). 
5.2.5 PEG microwell array fabrication 
PEG microwells were formed at the bottom of 96-well micro plate (BD) or 4-well plate (Nunc) by 
crosslinking 4arm-PEG-thiol (PEG-SH, 10kDa) with 8arm-PEG-vinboneulfones (PEGVS, 10kDa) at 5% 
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w/v. Hydrogel films were micropatterned by soft embossing with PDMS (polydimethylsiloxane, 
VWR) stamps for one hour to create an array of microwells. 
5.2.6 Single cell proliferation analysis by time-lapse microscopy 
Freshly isolated HSCs were seeded on the platforms. Platforms were directly placed on the time-
lapse microscope (Zeiss Axio Observer Z1 inverted microscope equipped with a motorized stage) for 
image acquisition. An incubation chamber maintaining temperature and CO2 levels allowed for live 
cell imaging. The stage was programmed to scan the microwell array surface and acquire images of 
multiple positions every 3 hours (30 min or 1 hour for the micro groove platform) for the duration 
of the culture period. Single cell proliferation kinetics were assessed based on time-lapse movies. 
5.2.7 Flow cytometry and cell sorting  
Flow cytometry analysis of hematopoietic stem and progenitor cells was performed on freshly iso-
lated bone marrow (BM) from 8-12 weeks old C57Bl/6J mice. BM was extracted from crushed fem-
ora, tibia and hip bone. Cell suspension was then filtered through a 70?m cell strainer and erythroid 
cells were eliminated by incubation with red blood cells lysis buffer (eBioscences). Lineage-positive 
cells were removed with a magnetic lineage depletion kit (Miltenyi Biotech). Cell suspensions were 
stained with a panel of specific antibodies for stem and progenitor cells and FACS-sorted on BD FACS 
Aria II. The hematopoietic stem cell (HSC) compartment was identified and sorted with the following 
cell surface phenotype Lin- Ckit+ Sca1+ (LKS) CD150+ CD48- CD34-. 
5.2.8 HSC culture 
All HSC cultures were maintained at 5% CO2 at 37o C in “Basal” media, Stemline II (Sigma) supple-
mented with 100ng/ml SCF (R&D Systems), 2ng/ml Flt3 ligand (R&D systems) and 0.5% P/S. “Differ-
entiation” media was made by supplementing Basal media with 20ng/ml IL3 (R&D Systems) and 
100ng/ml IL6  (R&D Systems). For uncoupler experiments, 5?M carbonyl cyanide 4-(trifluorometh-
oxy) phenylhydrazone (FCCP) (Sigma) was added to the “differentiation” medium every 24 hours. 
5.2.9 Single cell proliferation analysis 
Individual cells cultured in microwells were imaged on a Zeiss Axio Observer Z1 inverted microscope 
equipped with a motorized stage. An incubation chamber maintaining temperature and CO2 levels 
allowed for live cell imaging. The stage was programmed to scan the microwell array surface and 
acquire images of multiple positions every 3 hours. Single cell proliferation kinetics were assessed 
based on time-lapse movies. 
5.2.10 Micromanipulation of paired daughter cells for single cell analysis 
Single cells in microwells having undergone one division to give rise to two daughter cells were iden-
tified after 40 hours in culture. Paired daughter cells were isolated by micromanipulation in 20?m 
diameter micro capillaries (Eppendorf). Single cells were ejected from the micro capillaries into lysis 
solution for subsequent single cell PCR. 
5.2.11 Selection of candidate genes 
47 candidate genes listed in Table 4.1 were selected for expression analysis in PDCs. Some of those 
genes were identified in a microarray analysis where they were differentially expressed in HSCs 
compared to MPPs176, or compared to mobilized or leukemic HSCs177. These included, key cell sur-
face molecules such as JAM3, Tie2, ProCR, and Esam1; intracellular adaptor proteins Grb10 and Fhl1; 
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and, cycling dependent kinase inhibitor p57178. After a careful review of published work we included, 
cell cycle genes p21, p27, and p130, which were shown to be important in HSC quiescence179–181; 
HSC maintenance genes b-cat182, Pten183, and Gata3184; and, important self renewal mediators, 
HoxB4185 and c-myc186,187. With recent developments in the field that are strongly implying the role 
of metabolism in HSC fate choices, we included a variety of metabolic genes for our analysis. These 
included, a glucose transporter (Glut1), key glycolytic enzymes (HK2, PFKFB3, Ldha)50,188, enzymes 
involved in TCA cycle (CS, Acyl, Aco1, Suclg1, Mdh2), and some key components of the oxidative 
phosphorylation machinery. Based on recent work that implicated fatty acid oxidation as a key to 
HSC maintenance189, we included two acyl-coA dehydrogenases (MCad and Lcad) and an enzyme 
that facilitates the entry of fatty acids into the mitochondria (Cpt1a). With growing amount of infor-
mation on the detrimental effects of ROS on HSC function, we included two key antioxidants (SOD2 
and Cat) that were shown to be instrumental in keeping ROS levels low in HSCs31,188. 
 
Table 5.1: List of genes tested in single cell multi gene expression analysis. Table from Dr. Mukul Girotra’s thesis 
5.2.12 Single cell qRT-PCR 
Micromanipulated single cells were ejected in 0.2ml PCR tubes containing 10?l of Lysis solution (9?l 
single cell lysis solution+ 1?l single cell Dnase I). Cells were incubated in the lysis solution at RT for 
up to 30min followed by addition of 1?l of single cell stop solution and incubation at RT for up to 
20min. The samples were then stored at -20°C. Reverse transcription and pre-amplification were 
Classification Gene name  Classification Gene name     
House keeping gene HPRT  Glycolysis HK2 
ECM proteins Tgm2   PFKFB3 
 Bgn   Glut1 
Membrane proteins Esam1   Ldha 
 Tie2  TCA cycle CS 
 JAM3   Acly 
HSC markers CD150   Aco1 
 CD48   Suclg1 
 CD34   Mdh2 
 C-kit  Oxidative Phosphorylation Cyt-C 
Intracellular adaptors Grb10   NDUFA2 
 ProCR   COX2 (Sdhd) 
 Fhl1   ATP5g1 
 b-catenin   COX1 
Cell cycle regulators P57 (cdkn1c)   COX3 
 P27 (cdkn1b)   COX4 
 P21 (cdkn1a)  Mitochondrial biogenesis Mfn2 
 P130 (rab3gap)   Tfam 
 Pten  Antioxidants SOD2 
Transcription factors Pbx1   Catalase 
 Gata3  Fatty acid oxidation MCad 
 c-myc   LCad 
 Hoxb4   CPT1a 
DNA repair Gadd45    
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performed sequentially on the lysed cell sample using Single Cell-to-Ct Kit (Life Technologies). Con-
ditions for reverse transcription were 10min at 25°C, 60min at 42°C, and 5min at 42°C. Gene Expres-
sion TaqMan Assays (Life Technologies) corresponding to the gene set  (Table 4.1) were pooled and 
diluted at 0.2X in 1X TE buffer pH8.0 for pre-amplification. Samples were incubated for 10min at 
95°C and pre-amplified for 14 cycles of 15 sec at 95°C and 4 min at 60°C on a thermal cycler. The 
pre-amplified samples were diluted 1:15 in 1X TE buffer pH8.0 and stored at -20°C. Real-time quan-
titative PCR was performed with Gene Expression TaqMan Assays (Life Technologies) on a 7900HT 
system (Applied BioSystems). Conditions for amplification were 2 min at 50°C and 10 min at 94.5°C 
followed by 40 cycles of 5sec at 97°C and 1min at 59.7°C. Expression values over the threshold of 
the machine were set to 40 (ct=40). 
5.2.13 Immunostaining and images analysis in the multi groove platform  
At the end of the culture period, cells were fixed (4% PFA) and permeabilized (0.1% TritonX) before 
blocking with 10% goat serum on the platform. Immunostaining was performed using Glut1-
AlexaFluor 647 (1:500) (cat no: ab195020 Abcam), JAM3-FitC (1:100) (clone CRAM-18 F26, cat:no 
MCA5935F BioRad), and HK2 (1:500) (cat no: ab76959 Abcam) with a secondary antibody AlexaFluor 
555 (1:500) (cat no: A-21425 Thermofisher scientific). Z-stacks of paired-daughter cells were ob-
tained using a confocal spinning-disk microscope (NikonTi, Crest spinning disk with ANDOR EMCCD 
camera). Sum of pixels value of z-stack images were calculated to obtain the total protein expression 
of a cell. Image analysis was performed with ImageJ.  
5.2.14 Glut1 staining for FACS analysis 
Freshly sorted/cultured cells were stained with anti Glut1-PE (cat no: NB110-39113PE) for 1 hour at 
4°C followed by washing with PBS before being used for analysis. 
5.2.15 Transplantation  
Double congenic (CD45.1/45.2) marker system was used for transplantations. CD45.2 female mice 
were lethally irradiated (850RAD) and transplanted with donor cells isolated from CD45.1 mice and 
competitor cells from CD45.1/45.2 mice. Glut1 low and high subpopulations in LT-HSCs were FACS 
sorted. 75 donor cells were transplanted together with 250 *103 BM competitor cells. Recipient 
mice were bled at 4, 8 and 16 weeks post-transplant and peripheral blood was stained with specific 
antibodies to determine donor-derived chimerism. 
5.2.16 CFU assay 
Freshly isolated LT-HSCs were cultured for 3 days and directly stained with Glut1 (cat no: NB110-
39113PE, NovusBiologicals) and JAM3 (cat no: MCA5935, BioRad) antibody. Stained cells were re-
sorted based on Glut1 and JAM3 low and high signals. 35 collected cells of either population were 
plated in complete M3434 methylcellulose (Stem Cell Technologies) following the manufacturer’s 
instructions. Colony-forming cell mass was scored at day 8 and 10 using STEMvisionTM (an auto-
mated colony counting machine, StemCell technolgies). Colony categories (erythroid and/or 
megakaryocyte progenitor cells CFU-MK/E, granulocytes and/or macrophage progenitor CFU-
M/G/GM, and multi-potential progenitors (CFU-GEMM) were evaluated by visual inspection. 
5.2.17 Statistics 
Data was statistically analyzed by student t test, Mann-Whitney test, Spearman’s rank correlation 
coefficient was determined for correlation analysis. 
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5.3 Results 
5.3.1 In vivo activation of HSCs by IFNa increases asynchronous cell divisions 
We used interferon-? (IFNa) treatment as a model to push HSCs out of their dormant state in 
vivo50,174. HSCs from IFNa treated and control mice were FACS sorted based on a combination of cell 
surface markers regularly used in the field, such as Lin-ckit+Sca1+ (LKS) CD150+CD48-CD34-13,166,190, 
and immediately fixed and stained to determine their cell cycle status (Figure 5.1A). As previously 
shown, the IFNa treatment resulted in a significant increase in the proportion of cycling HSCs (Ki67 
positive) (Figure 5.1B). We next assessed the proliferation kinetics of freshly isolated control and 
IFNa-activated single HSCs using a platform with micro-grooves array made in pHEMA-TMPTA in 
combination with live cell imaging (Trachsel et al., Submitted; Vannini et al., In preparation). The 
platform was developed to allow single cell trapping and lineage tracking of rare and sensitive cells 
(such as HSCs). In brief, single cells were captured in individual micro-grooves by gravity and were 
restricted to grow in a line. To avoid a cell from interchanging its position with other cells, the micro-
grooves were closed with a permeable lid made in self-assembling polyethylene glycol (PEG) poly-
mer. Therefore, this platform allows unambiguous tracking of single cells over multiple generations. 
Using the platform, we measured single cell behavior and division dynamics in high throughput over 
a period of up to five days (Figure 5.1D-F). As expected, the IFNa-activated HSCs carried out the first 
division faster when compared to the control HSCs (Figure 5.1F). The time until half of the popula-
tion had carried out a cell division was around 53 hours for control HSCs and was shortened by 
approximately 8 hours in IFNa treated cells (Figure 5.1F), confirming the IFNa treatment as a reliable 
model for HSC activation in their native bone marrow niche. Moreover, the proliferation curves 
showed similar average expansion over a period of five days (Figure 5.1E), demonstrating that acute 
IFNa treatment leads to transient activation and not an uncontrolled proliferation of HSCs, as shown 
by previous studies174. We observed similar division kinetics on the PEG microwell plat-
form73,111,120,129, confirming our results on two different single cell platforms (Supplementary Figure 
S5.1) 
One key property of the HSCs is their slower cycling rates as compared to their progenitors111,164–
166. Therefore, we hypothesized that an analysis of the proliferation kinetics of the first generation 
of HSC daughters could reveal information on the maintenance of stem cell properties such as 
slower cycling rates. We assessed the difference in time of division of PDC to define the synchrony 
?????????????????????????????????????hter cells was defined here as asynchronous if the ??????????????
than 6 hours (Figure 5.1G). We observed that the proportion of asynchronous divisions was higher 
(Figure 5.1H) and the average asynchrony time was significantly longer in IFNa-activated HSCs when 
compared to controls (Figure 5.1I). Corresponding analysis on the PEG microwell platform con-
firmed this observation (Supplementary Figure S5.1). This increase in asynchrony suggested a pos-
sible increase in asymmetric division where one daughter retains stem cell potential (slow cycling) 
whereas the other daughter undergoes commitment (fast cycling), supporting earlier evidence in 
the field for the production of two non-identical daughter  
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Figure 5.1: In vivo activation of HSCs by IFNa increases asynchronous cell divisions. (A) HSCs were freshly isolated from the bone 
marrow using Lin- cKit+ Sca1+ CD150+ CD48- CD34- markers. 
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cells with different colony forming and blood reconstitution levels in vitro38,171–173.  
5.3.2 Identification of the asymmetric gene set using PDC gene expression analysis 
We, and others, have previously demonstrated how acute activation by IFNa results in HSC self-
renewal without the loss of stem cell potential50,174. Since IFNa mediated activation occurs in the 
native bone marrow niche without loss of stem cell potential and leads to an increase in asynchro-
nous divisions in vitro (Figure 5.1H, Supplementary Figure S5.1E), we hypothesized that this could 
be a suitable system to study niche-instructed HSC fate choices and, specifically, the process of ACD. 
To test this, we performed the multi-gene expression analysis in PDCs and compared the gene ex-
pression profiles of sister cells. To this end, we isolated IFNa-activated HSCs from the bone marrow 
and cultured them as single cells in PEG microwells in basal serum-free culture condition in order to 
follow their proliferation kinetics (Supplementary Figure S5.2A). The PEG microwell system is an 
open system that allows easy access to cells for their collection. Upon division, the PDCs were iso-
lated from microwells by micromanipulation (Supplementary Figure S5.2B) and analyzed for their 
gene expression profile using single cell quantitative RT-PCR. We shortlisted 47 candidate genes for 
expression analysis (described in experimental methods) on every cell. These genes belonged to 
various metabolic pathways or were earlier identified as important regulators of HSC function. All 
candidate genes were analyzed in 24 sets of PDCs. Strikingly, when the Log2(Ct) values of the two 
cells were plotted against each other, different genes showed distinct patterns of expression. The 
qualitative analysis revealed that, on one hand, some candidate genes demonstrated symmetric 
expression behavior with almost all pairs found close to the diagonal (Supplementary Figure S5.3A). 
On the other hand, various genes were asymmetrically expressed (Supplementary Figure S5.3B), 
with one cell of the pair expressing the gene at higher levels (low Ct) and the other at lower levels 
(high Ct). However, for most of these potentially asymmetric genes, a sub population of pairs that 
appeared close to the diagonal (Supplementary Figure S5.3B) remained, suggesting that not all pairs 
are carrying out ACD. 
In order to identify the most asymmetrically expressed gene set, we assigned a quantitative value 
to every gene to determine where it ranked in comparison to the others. To this end, we obtained 
the average ?Ct for every gene across all pairs and designated it as “Gene score”. 
???? ????? = 1?? ? (???
? ?????
???
)?           ????? ??? = |?? ????? ?  ?? ?????| 
A gene score of 1 indicated an average 2-fold difference in expression in the PDCs, which incre-
mented to 4-, 8-, 16- and 32-fold with gene scores of 2, 3, 4 and 5. We found a huge range of this 
score with some genes as low as 0.195 (~1.15 fold difference) and others as high as 5 (~32 fold 
 
(B) Cell cycle analysis using Ki67 and Hoechst staining on freshly isolated HSCs from control and IFNa treated mice. Cells in red 
box (Ki67 positive) constitute a fraction of HSCs in a cycling state (G1+S/G2-M phase). (C) HSCs isolated from IFNa treated mice
show a significant increase in the cycling fraction (Ki67 positive cells). (D) Single cell proliferation kinetics analysis using live cell 
imaging of HSCs pHEMA-TMPTA micro-grooves platform (Trachsel et al.,  Submitted. (E-F) Proliferation kinetics of live and dividing 
HSCs isolated from control and IFNa administered mice. The average proliferation over 5 days remains similar in the two condi-
tions, with IFNa activated cells carrying out the first division much faster (~8h) when compared to control HSCs. (G) Representative 
example of synchronous division (top) and an asynchronous division (below) with ?T? 6 hours being used as a threshold. (H) IFNa 
activated HSCs show a notable increase in the proportion of asynchronous divisions. (I) IFNa activated HSCs show a significant 
increase of asynchronous-time division between daughter cells. ***P< 0.001, **P< 0.01 and *P< 0.05 
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difference) (Figure 5.2B). We applied a stringent (although arbitrary) threshold of 10-fold difference 
to identify a set of most highly asymmetric genes from our candidate list. 12 genes were found to 
be above this threshold (Figure 5.2B (in red), Figure 5.2C). This set included genes controlling differ-
ent metabolic pathways such as glycolysis and TCA cycle as well as conventional HSC markers such 
as JAM3 and CD150. 
Having identified a set of asymmetrically expressed genes, we next checked the asymmetry associ-
ated in individual pairs linked to this gene set. To obtain a single quantitative readout of symmetry 
for a pair, we calculated the Euclidian distance between the two sister cells by summing up the 
square ?Ct value for all genes in the “asymmetric” gene set and calculating its square root. We called 
this value the (A)symmetry index (A.I) for a pair. Here, a higher value of A.I reflected a greater asym-
metry in expression. 
?. ????? = ?? ? (?? {???? ?} ? ?? {???? ?})?
? ?????
???
?           
Pairs with high A.I value (representative examples shown in Supplementary Figure S5.3) had asym-
metric expression of these genes, and, very often, the expression was restricted to only one cell of 
the pair (Supplementary Figure S5.3) whereas, in pairs with low A.I value (representative examples 
shown in Supplementary Figure S5.3), most genes were expressed symmetrically and were found 
very close to the diagonal (Supplementary Figure S5.3). A comparative analysis revealed that IFNa-
activated pairs had significantly higher values of A.I than their control counterparts (Figure 5.2D), 
suggesting that it can be used as a suitable model to study the link between expression and asym-
metric fate in HSCs. 
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Figure 5.2: Identification of asymmetric gene and protein expression in PDCs. (A) Freshly isolated HSCs tracked during culture until 
first division (35h) using a time-lapse microscope. A microwell array platform was used for the gene expression analysis and a micro-
groove platform for protein expression analysis (Figure S2). (B) The gene score values show a wide variation from one gene to 
another. A stringent threshold (average 10-fold difference in gene expression between PDCs) was put to identify the “asymmetric 
gene set”. (B-C) Figures adapted from Dr. Mukul Girotra’s Thesis (C) Table showing 12 candidate genes that were seen to cross the 
10-fold threshold (fold change values in table). (D) IFNa treated PDCs show a higher asymmetry when Index compared to control 
PDCs. (E) Representative immunofluorescent images showing asymmetric expression of Glut1, JAM3 and HK2 in 5 PDCs. (F-G) Anal-
ysis of PDCs asymmetry for Glut1 (n=59 control, n=72 IFNa), JAM3 (n=64 control, n=69 IFNa treatment) and HK2 (n=32 control, 
n=54 IFNa) with IFNa treated cells or control. (F) PDCs asymmetry in frequency with threshold defining “asymmetric protein ex-
pression” used in (H): Glut1=1, JAM3=1, HK2=0.3. (G) PDCs asymmetry. Boxplot’s interquartile range from 25th to 75th percentile. 
Line and red square shows respectively median and mean, and the error bar is SD (outliers lower or upper inner fence is equal to 
1.5 the interquartile range) (H) The protein expression pattern in PDCs (all PDCs considered) for Glut1, JAM3 and HK2. Asymmetry 
with one marker (first column) are shown in total percentage (without considering other markers). A double asymmetry (two asym-
metric proteins) analysis is showed in the second column. An asymmetry comprising two proteins (for example “P1” and “P2”) on 
two daughter cells (defined by ca and cb) may be either “coinciding”—a cell having high expressions of both proteins “A” “B” 
(phonetically defined by ?? ???? ==??, ?? ???? =?? )—or “diametrical”—a cell having more than one protein “P1”” but less than of “P2” 
 ?? ???? =?? and, conversely, his sister more than one protein “P2” and less than “P1” ?? ???? =?? . ***P< 0.001, **P< 0.01 and *P< 
0.05.  
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5.3.3 Analysis of the protein expression of Glut1, JAM3 and HK2 by immunofluorescent stain-
ing  
Having identified a list of 12 highly asymmetric candidates using gene expression analysis, we fur-
ther went on to analyze whether this asymmetry holds true at the protein level. We selected three 
candidates, namely, Glut1, JAM3 and HK2, to check their expression in paired daughter cells.  
To this end, we used the micro-groove platform, which allows high throughput tracking of single 
cells (Figure 5.1 and Supplementary Figure S5.2). Single cells were seeded onto the grooves and 
followed by time-lapse microscopy. Upon division, the PDCs were fixed and stained for immunoflu-
orescence (Supplementary Figure S5.2C). Importantly, the closed micro groove platform allows cell 
encapsulation without a mix up of cells between different grooves during various staining steps. 
This results in a high throughput analysis of PDCs that is currently lacking in the field (Trachsel et al., 
Submitted). We compared the protein expression between sister cells (denoted by ?? ??? ?? ) using 
confocal microscopy and obtained an index of asymmetry at the protein level, calculated as follows:  
?. ???????? =
??? ??
??
, with ??>?? . 
The preliminary analysis revealed that some PDCs are very symmetric (?. ????????<0.01) (Supplemen-
tary Figure S5.4) while others are extremely asymmetric (Figure 5.2E) (?. ????????>100) both in con-
trol and IFNa-treated cells. In total, we analyzed 131 pairs for Glut1, 133 for JAM3 and 86 for HK2. 
To the best of our knowledge, this is the first study in which such a high number of HSC daughter 
pairs are analyzed for their protein expression by immunofluorescence at the single cell level. Our 
analysis revealed that with the IFNa treatment, PDCs exhibit significantly higher levels of asymmetry 
in Glut1, JAM3 and HK2. Particularly, Glut1 and JAM3 showed very high asymmetry values, suggest-
ing their importance in mediating an asymmetric cell division in HSCs. Surprisingly, HK2, which was 
the most asymmetric candidate identified in the gene expression analysis, showed only a mild in-
crease (although significant) in the protein asymmetry associated with IFN treatment (Figure 5.2G). 
In line with our asynchrony data (Figure 5.1) that suggested an increase in ACD with IFNa treatment, 
we found a concomitant increase in the frequency of high asymmetric segregation of all the three 
markers in the IFNa condition (Figure 5.2F). 
To obtain a more comprehensive phenotype of PDCs, we analyzed co-stainings of Glut1, JAM3 and 
HK2 (n=69 IFNa n=63 control for Glut1/JAM3, n=30 IFNa n=26 control for Glut1/HK2, n=30 for IFNa, 
n=26 for control JAM3/HK2). We applied a threshold of AIprotein equal to 1 (this corresponds to one 
sister having 100% more expression over the other) to identify asymmetric PDCs. However, since 
the overall asymmetry with HK2 was smaller, we lowered the threshold for HK2 to 0.3 (this corre-
sponds to one sister having 30% more expression over the other) (Figure 5.3F). 
As expected, we found that in the IFNa condition, Glut1 and JAM3 are more asymmetric individually 
(Figure 5.3H top and middle left panel). We next looked within these asymmetric pairs for double 
“diametrical” asymmetry and found it in 12% of IFNa PDCs (2% in control). This shows that one 
daughter cell exhibits higher expression of one marker and lower expression of the other when 
compared to its sister cell (i.e., first daughter has Gluthigh JAM3low while the second daughter has 
Glutlow JAM3high). In contrast to diametrical asymmetry, only 2% of IFNa PDCs had a “coinciding” 
asymmetry (both markers expressed more on the same daughter cell) and 12% in control. Interest-
ingly, both markers were symmetrically expressed in 51% of control PDCs and only 29% of IFNa 
PDCs. This data suggested a different signature in asymmetry expression in control and IFNa cells. 
Previous studies have shown higher JAM373,191,192 and lower Glut1 expression175 on functional HSCs. 
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Therefore, we hypothesized that PDCs with Glut1low JAM3high phenotype could represent a more 
primitive cell type when compared to other combinations. 
Moreover, we think that cell surface markers Glut1 and JAM3 can be used as reliable markers in 
functional assays for future analysis. Nevertheless, we tried co-staining with the other combinations 
(i.e., Glut1/HK2, JAM3/HK2) and confirmed the increase in asymmetry in the IFNa-treated PDCs (Fig-
ure 5.3H middle and bottom panel).  
5.3.4 Characterization of Glut1 and JAM3 as markers for ACD in mHSCs 
Many previous studies have highlighted the critical role of glycolytic metabolism in HSC fate deter-
mination32,50,156,188. Therefore, we further analyzed the protein expression levels of Glut1 whose 
glucose transporting activity would directly impinge upon the glycolytic and mitochondrial oxidative 
phosphorylation activities in the cell. Moreover, as a cell surface protein, it serves as an ideal candi-
date that allows the simultaneous estimation of protein expression levels by flow cytometry and 
stem cell potential through various functional assays. To this end, we first estimated the Glut1 ex-
pression by flow cytometry in different cell populations of the hematopoietic hierarchy. Strikingly, 
we found a stepwise increase in the Glut1 expression from the most primitive population (HSCs: LKS 
CD150+CD48-CD34-) to the more committed cell types (ST-HSC: LKS CD150+CD48-CD34+ and MPP: 
LKS CD150-) (Figure 5.3A). This agrees with previous studies estimating Glut1 levels in HSCs175. To 
test if the lower Glut1 imparts better functionality to HSCs, we sub-fractionated the HSCs into Glut1 
low and high and transplanted them in irradiated recipients. We found that the Glut1 low subpop-
ulation of HSCs shows higher long-term blood reconstitution potential (Supplementary Figure S5.5). 
The differential expression pattern of Glut1 in HSCs and progenitors plus higher stem cell potential 
of Glut1 low subpopulation suggested that it could be used as a potential marker to identify asym-
metric cell division.  
We further assessed the Glut1 expression in HSCs after 3 days of in vitro culture in pre-defined con-
ditions. HSCs cultured in the Basal media showed a small decrease in the Glut1 low fraction (Figure 
5.3B). Strikingly, the HSCs cultured in differentiation inducing “IL3/6” condition (Vannini et al., 2016) 
showed a dramatic increase in the Glut1 expression, almost resulting in the disappearance of the 
Glut1 low fraction. Intriguingly, the addition of a chemical uncoupler “FCCP” to these differentiation 
inducing conditions, previously shown to maintain stem cell potential (Vannini et al., 2016), com-
pletely reverts the profile of Glut1 expression (Figure 5.3B). This observation provides an indirect 
link between Glut1 expression and HSC fate.  
To further characterize the “diametrical” asymmetry that we observed in Glut1 and JAM3 (Figure 
5.2H), we sorted out the four populations after 3 days of in vitro culture (ensuring that the cells had 
divided). 35 sorted cells of each population were plated on methylcellulose and assessed for the 
ability to form different colonies. We found Glut1low JAM3high to be the only population showing 
emergence of GEMM colonies at 8 and 10 days post plating (Figure 5.3C), clearly indicating that the 
primitive cells post division are residing in this population. This phenotype is in line with previous 
studies showing high JAM3 and low glut1 in functional HSCs73,175,191,192. 
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Figure 5.3: Characterization of Glut1 and JAM3 as markers for asymmetric division in HSCs. (A) Expression of Glut1 was tested in
different populations of the hematopoietic hierarchy using flow cytometry. Long term HSCs (LT-HSCs: LKSCD150+CD48-CD34-),
short term HSCs (ST-HSCs: LKSCD150+CD48-CD34+) and multipotent progenitors (MPPs: LKSCD150-) were identified using a com-
bination of cell surface markers and stained with Glut1 to be analyzed by flow cytometry. Glut1 levels changed dramatically from 
the LT-HSCs (Glut1 low ~40%) to ST-HSCs (Glut1 low ~9%) to MPPs (Glut1 low ~1.5%) with concomitant increase as we moved down 
in the hematopoietic hierarchy. (B) Glut1 expression in LT-HSCs after 3 days of in vitro culture was assessed using flow cytometry.
HSCs cultured in Basal media showed a small loss of Glut1 low fraction as compared to fresh uncultured LT-HSCs. Differentiation
inducing (IL3/6) condition shows a striking loss of Glut1 low fraction with the overall Glut1 levels going up. The addition of FCCP
(mitochondrial uncoupler) to the IL3/6 condition reverts this loss of Glut1 low fraction and brings down the level of Glut1 expres-
sion. (A)-(B) From Dr. Mukul Girotra’s thesis (C) LT-HSCs were cultured for three days and were sorted based on Glut1 and JAM3. 
The stem cell potential of these sorted cells was determined by their Colony forming (CFU assay) ability. Glut1 low JAM3 high cells
showed a significant increase in the proportion of more primitive (GEMM) colonies and concomitant decrease in the less primitive
(Mk/E) colonies, suggesting that Glut1 low JAM3 high cells are more primitive than other populations (i.e., Glut1 high JAM3 low,
Glut1 high JAM3 high, Glut1 low JAM3 high). (CFU-)G: Colony forming unit-granulocyte; (CFU-)M: Colony forming unit-macrophage; 
(CFU-)GM: Colony forming unit-granulocyte, macrophage; (CFU-)GEMM: Colony forming unit-granulocyte, erythrocyte, macro-
phage, megakaryocyte); Mk/BFU-E: Megakaryocyte/Burst forming unit-erythroid. (D) Bone marrow from healthy adult human or-
theopedic donors were stained with different HSC and progenitor markers. The Glut1 low fraction reduced dramatically from the 
HSC containing population CD34+CD38-CD45RA- (~73%) to the progenitor populations CD34+CD38+ (56%) and CD34- (47%). 
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5.4 Discussion 
Here, we report a unique experimental strategy to analyze niche-instructed fate choices in HSCs. 
IFNa mediated activation was used as a model to study ACD in murine HSCs. Live cell imaging re-
vealed a significant increase in the asynchronous divisions in activated HSCs, suggesting the execu-
tion of a niche-instructed ACD program. Previous studies in invertebrates have elegantly demon-
strated the role of the niche in orchestrating ACD. For example, in Drosophila, a close association 
with the niche (cap cell in the ovary and hub cell in the testis) is instrumental in the execution of the 
ACD of germline stem cells. Instructive cues from the niche lead to the activation of BMP (in ovary) 
or JAK-STAT (in testis) signaling, which eventually represses the differentiation in the daughter cell 
destined to maintain stemness 193–196. PDC analyses in the hematopoietic system have revealed dif-
ferent colony forming potential171,172 and in vivo reconstitution ability38,173 in sister cells, suggesting 
the occurrence of ACD in HSCs. However, the precise mechanisms that regulate this fate choice are 
currently unknown. 
Our single cell gene expression analysis in PDCs allowed the identification of an asymmetric gene 
set. Among them were some genes that have been described in the literature as important for HSC 
identification, such as CD15013, Tie2197 and JAM373. Interestingly, Tie2 (receptor of Ang1) has been 
previously used as an asymmetry marker189. We also identified some metabolic genes such as Glu-
cose transporter 1 (Glut1), Hexokinase 2 (HK2) and Aconitase 1 (Aco1) as highly asymmetric in PDCs. 
Glut-1 facilitates the transport of glucose across the cell membrane and has been previously shown 
175 to be expressed more in the progenitors as compared to HSCs. Moreover, HK2, a glycolytic en-
zyme involved in the conversion of glucose to glucose-6-phosphate, was shown to be upregulated 
by HIF1a198, a key component involved in the HSC function188. The identification of these two candi-
dates confirms earlier reports on the importance of glycolytic pathways in the regulation of HSC 
function32,188. The asymmetric expression of Aco1, an important TCA cycle enzyme in the mitochon-
dria converting citrate to iso-citrate, fitting well with our previous finding implicates mitochondrial 
activity as a determinant of the HSC fate50. 
Our results on the gene expression asymmetry were quite striking. We went ahead and explored if 
this asymmetry is maintained at the level of protein expression. To this end, we employed a platform 
that allowed us to quantify protein expression in paired-daughter cells using immunofluorescent 
staining. The asymmetric expression analysis at the protein level revealed significantly higher asym-
metric protein expression in the three chosen candidates, suggesting the maintenance of asym-
metry post translation. Co-staining with two markers showed higher double asymmetry in IFNa 
treated cells, suggesting it to be a good model for studying ACD in HSCs.  
Our functional analysis using CFUs revealed Glutlow JAM3high to be the most primitive subset in cul-
ture. This is in line with previous reports showing lower Glut1175 and high JAM373 in functional HSCs. 
To better understand the expression of Glut1, we sorted the different cells of the hematopoietic 
hierarchy and checked their Glut1 levels. Flow cytometry analysis revealed that the Glut1 expression 
systematically increases as one moves down in the hematopoietic hierarchy, which confirms the 
observations of Sarrazy et al.175. Moreover, HSCs with lower Glut1 expression showed higher long-
term blood reconstitution potential (Supplementary Figure S5.5). Furthermore, when the HSCs were 
put in pre-defined in vitro cultures, the Glut1 expression was higher in differentiation-inducing con-
ditions (IL3/6) as compared to conditions (IL3/6+FCCP) that we previously exhibited as conducive to 
stem cells in culture50.  
Analysis of asymmetric markers in the first generation of cells derived from murine HSCs 
85 
At first, the lower expression of Glut1 appears to be counter intuitive as HSCs have been previously 
shown to be more glycolytic when compared to progenitors128,156,188. However, HSCs are also known 
to express lower levels of global protein synthesis relative to differentiating progenitors199 . We 
think our data does not reflect the glycolytic flux but, in general, a lower expression of Glut1 in 
functional HSCs maintained post an asymmetric division in culture. 
We believe that having a mechanistic understanding of niche-instructed cell fate choices in HSCs is 
important in basic stem cell biology and also holds immense clinical potential to design future in 
vitro culture systems for a controlled expansion of HSCs. 
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Supplementary information for chapter 5 
 
 
 
 
 
 
 
 
 
Figure S 5.1: In vivo activation of HSCs by IFNa increases the asynchronous cell divisions. (A) Single cell proliferation kinetics analysis
using live cell imaging of HSCs in PEG microwells. (B-C) The proliferation kinetics of HSCs isolated from control and IFNa administered
mice. The average proliferation over 5 days remains similar in the two conditions, with IFNa activated cells carrying out the first
division much faster (~9h) as compared to control HSCs. (D) A representative example of synchronous division (top) and an asynchro-
?????????????? ???????????????????????????????????????? ??????????? ??) IFNa activated HSCs show an increase in the proportion of 
asynchronous divisions. (Figure from Dr. Mukul Girotra’s Thesis) 
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Figure S 5.2: Gene and protein analysis of PDCs from IFNa-activated HSCs. (A) Freshly isolated HSC were cultured onto PEG mi-
crowells (B) (Lutolf et al., 2009) or pHEMA-TMPTMA micro-grooves (C) (Trachsel et al., Submitted) and allowed to carry out a 
division. (B) Micromanipulation of paired daughter cells (PDCs) generated from a single HSC after one division for multi-gene ex-
pression analysis using PEG microwell platform. (C) A protein expression analysis of PDCs generated from a single HSC after one
division using pHEMA-TMPTMA micro-groove platform. Image (B) is adapted from Dr. Aline Roch’s Thesis 
Figure S 5.3: Qualitative analysis of the distribution of gene expression in PDCs. Each gene is shown for the expression of 24 pairs 
of cells, with each dot representing a pair. (A) Representative examples of genes showing symmetric expression across most pairs.
Most pairs appear close to the “symmetric diagonal” (in red). (B) Representative examples of genes showing asymmetric expression
in pair daughter cells. Most pairs appearing far away from the “symmetric diagonal” (in red). Interestingly, most of these genes
have a subpopulation of pairs that show symmetric behaviour. (Figure from Dr. Mukul Girotra’s Thesis) 
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Figure S 5.4: Representative examples of symmetric expression of Glut1, JAM3 and HK2 in daughter cell pairs. 
Figure S 5.5: Multi lineage blood reconstitution potential of Glut1low and high subpopulations. (A) Fresh LT-HSCs were sub fraction-
ated in Glut1low and high populations. The two-sorted fractions were injected in lethally irradiated recipients. (B) Glut1 low fraction 
shows higher levels of multi lineage long-term blood reconstitution potential. 
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 Fate analysis of CD8+ T cell at the 
single cell level
Abstract  
A host organism mounts a well-orchestrated immune response upon microbial infection. Cytotoxic T lymphocytes (CD8+ T cells) are 
an important arm of this immune response and generate various subsets to protect the organism against the pathogen. It was re-
cently shown that these different T cell subsets, namely, the effector and memory cells, emerge from a common CD8+ T cell ancestor. 
However, it remains to be elucidated when and how this cellular diversity arise from a single T cell precursor. It was recently proposed 
that asymmetric cell division could be one mechanism through which two distinct daughter cells are generated as early as the first 
division. In the present chapter, we proposed a novel method that allows further characterization of T cells progeny in order to 
understand when and how this fate decision happens. We tracked single cells to observe if the first division is polarized during antigen 
presenting cell (APC) mediated activation. Moreover, we demonstrated that the immunological synapse (contact between T cell and 
APC) could also be studied using with our method. 
6.1 Introduction 
It has recently been shown that a single CD8+ naive T cells can give rise to effector and memory T 
cell progenies200–202. While the effector cells are short-lived and mediate acute protection against 
the pathogen, memory T cells have long lives and provide long-term protective immunity. However, 
how and when these different fates arise from a single cell (i.e., the diversification) remains a mys-
tery. Moreover, the underlying mechanisms guiding this process are not fully understood. Suggested 
mechanisms are that T cells divide asymmetrically at a certain time or that a subset of T cell pro-
gressively diverge from the effector pool to form the memory T-cell population. Asymmetric division 
(AD), where one daughter proliferates and differentiates whereas the other daughter remains iden-
tical to the mother (maintaining the stem cell pool), is a process that has been well-established for 
stem cells. This allows rapid expansion of a cell population without compromising the integrity of 
the precursor cell. This phenomenon could potentially occur during multiple phases upon lympho-
cyte activation by an antigen-presenting cell (APC)203: 1) during the initial divisions after its activa-
tion, 2) during the T cell proliferation, or 3) during the contraction phase where cells die and only a 
small subset of cell remains alive to form the memory T cell pool204. One hypothesis envisages “the 
late divergence model” where the T cell diversification (appearance of memory T cells) happens 
after the expansion phase. In contrast, the “early divergent model” proposes that some T cells are 
already primed as memory T cells after the first division205. It is important to note that these models 
are not mutually exclusive. Recently, Chang et al.206 compared two daughter cells arising from the 
first T cell and found notable differences in their protein expression. Strikingly, they were able to 
correlate these differences with a tendency of cells toward effector or memory fates, suggesting 
that the cells are already pre-instructed toward a distinct lineage during the first division. Chang et 
al.’s206 observations are particularly in support of the early divergent model. Since the diversification 
may happen as early as the first division while one cell is still in contact with the APC, it was proposed 
that APCs could provide cues that promote AD. In line with this hypothesis, the same authors 
showed that the position of cells with respect to the APC seems to determine which daughter cell 
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will acquire an effector fate and which one will take on the memory fate. The proximal cell (close to 
the APC) possessed more CD8 and CD44 proteins, were larger in size and expressed low level of 
CD62L, a profile consistent with “pre-effector” lineages206. In contrast, the distal daughter cell had 
a memory-like profile with a high level of CD62L but low CD44 expression; additionally, they were 
small206. Consequently, it is possible that the contact between a T cell and an APC (called the immu-
nological synapse) that precede the first T cell division trigger the different fates between daughter 
cells. In line with this hypothesis, King. et al. demonstrated that the strength and affinity of T cells 
with APCs directly influences T cells polarization and, consequently, causes an asymmetric divi-
sion207.  
Current experiments that allow the observation of daughter T cells require the addition of drugs to 
arrest the cells in the final phase of mitosis (i.e., Cytochalsin B or Nocodazole)206,208,209. Conse-
quently, the two daughter cells are still connected and have not mixed with the rest of the cells in 
the culture, which leads to unambiguous asymmetry studies. However, an inhibition about mitosis 
prevents the analysis of subsequent lineages derived from each daughter cell. Lineage tracing anal-
ysis would greatly help to correlate the observations made on the asymmetric distribution of pro-
teins between daughter cells after the first division with their respective progeny.  
As previously explained, the interaction between the T cell and an APC at the immunological synapse 
seems to dictate the fate of daughter T cells205,210. Therefore, being able to observe the immunolog-
ical synapse with a concomitant analysis of daughter cells would enable new understandings about 
their interactions. To this aim, Oliaro et al.211 proposed a method that permitted the study of protein 
expression in daughter cells and an immunological synapse with the APC. In this approach, the an-
tigen presentation was performed in vitro by seeding naive CD8+ T cell on pre-fixed antigen-primed 
dendritic cells. Cells were then fixed and stained for quantification, and the protein expression quan-
tifications were made on cells that were in late-telophase. This experiment provided new insights 
into the role of APC to modulate the asymmetric division of T cell. This approach could not prevent 
the proximal and distal cell from changing their respective position and, therefore, can lead to inac-
curate conclusions. More importantly, it was not possible to track daughter cell lineage after the 
first division. Collectively, these studies outline the critical need for a device that enables single T 
cell tracking over several generations in order to study the T cell fate. 
To overcome the current limitations on T-cell progeny analysis and T-cell interaction with the APC, 
we attempted to establish a new methodology to observe and analyze the T cell lineages at the 
single cell level. The general aim is to observe the entire process, from the antigen presentation in 
a T cell to its proliferation. To enable T cell activation and lineage tracking, a co-culture of T cell with 
an APC is performed on the micro-groove tracking platform (Trachsel et al., Submitted). Not only 
would it provide meaningful information on how the immunological synapse changes T cell fate, it 
would allow a more precise estimation of when and how the dissociation between effector and 
memory cell happens. Here, we showed the first steps toward the achievement of this general aim. 
6.2 Material and method 
6.2.1 CD8+ T cells extraction 
OT-I transgenic mice 20 weeks old were used for T cell extraction. Naïve CD8+ T cells were purified 
from spleens using the EasySep mouse CD8+ T cell Isolation Kit (Stem Cell Technologies). Briefly, 
spleens were disrupted in PBS and cell suspension was then filtered through a 70 ?m cell strainer. 
Erythroid cells were eliminated by incubation with red blood cells lysis buffer (eBioscences). Cells 
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were incubated with a cocktail of antibodies that target non-CD8+ T cell followed by a second incu-
bation with streptavidin-coated magnetic beads. Cell suspension was placed in an Easysep magnet 
and negative selection of CD8+ T were then performed by collecting cell suspension in a new tube.  
6.2.2 EG7 cell culture 
EG7 cells were maintained in RPMI 1640 supplemented with 10% (v/v) heat-inactivated fetal bovine 
serum (FBS), 50 ?M ?-mercaptoethanol, Penicillin-Streptomycin (all from Gibco, Switzerland) and 
400 ?g/ml G418 (Brunschwig). Cells were then cultured in an incubator at 37°C and 5% CO2.  
6.2.3 EG7 irradiation dose titration  
EG7 cell suspension were washed and place in Eppendorf tube at a concentration of 106cells/ml in 
PBS. Tubes were placed in a gamma irradiator and exposed to different doses as follow: 0, 10, 30, 
40, 50, 60 and 70 Gy. To assess proliferation of EG7 post-irradiation, cells were stained with cell 
trace violet (CTV, Thermofisher) following manufacturer’s information and then cultured in round 
bottom 96-well plates. Cells were harvested every 24h, stained with propidium iodide (PI, Ther-
mofisher) and analyzed on a LSR Fortessa flow cytometer (Becton Dickinson).  
6.2.4 Activation of OT-I CD8+ T cells and analysis 
Freshly isolated CD8+ T cells from OT1 mouse were stained with CTV and co-cultured with irradiated 
EG7 (40Gy) cells at a ratio of 1:2. Cells mix was cultured in round-bottom 96-well plates in “activation 
medium” made of RPMI 1640 supplemented with 10% (v/v) heat-inactivated fetal bovine serum 
(FBS), 50 ?M ?-mercaptoethanol, Penicillin-Streptomycin (all from Gibco, Switzerland), 50U IL-2. 
Every 24h, cell mix was harvested stained with anti-CD8-Bv650, anti-CD44-APC-Cy7, anti-CD62L-
FITC, anti-CD27-PerCPCy5.5, and anti-CD69-PE (all from Biolegend), PI and analyzed on LSR Fortessa 
cytometer (Becton Dickinson).  
6.2.5 Time-lapse imaging  
For the study of immunological synapse, freshly isolated CD8+ T cells and irradiated EG7 cells (40Gy) 
were mixed at a concentration of 105 cells/mL at a ratio of 1:1 and cultured on the micro-groove 
platform (Trachsel et al., Submitted) (in activation medium). Brightfield images were captured every 
30mn on a Zeiss Axio Observer microscope using a 10x air objective. 
For the study of CD8+ T cell progeny, freshly isolated CD8+ T cells and irradiated EG7 cells (40Gy) 
were mixed at a concentration of 105 cells/mL at a ratio of 1:1 and cultured for 18h (in activation 
medium). Cells were then seeded onto a micro-groove array platform (Trachsel et al., Submitted) 
and cultured for 1 day in activation medium containing 150U IL2. Brightfield images were captured 
every 30mn on a Zeiss Axio Observer microscope using a 10x air objective. Alternatively, for fluores-
cent imaging a Nikon Ti microscope were used. Anti-CD8a conjugated to AF647 (BioLegend) and 
CD62L-AF488 (BioLegend) were added to the culture medium. Z-stack images were acquired prior 
and after cell divisions at 60x.  
6.2.6 Image analysis 
Sum of pixels value of z-stack images were calculated to obtain the total protein expression of a cell. 
Image analysis was performed with ImageJ. 
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6.3 Result and discussion 
In the present study, we explored a new methodology that enabled not only the study of the immu-
nological synapse between a naive CD8+ T cell and an APC, but also an analysis of the progeny de-
rived from the T cell after its activation. In contrast to standard in vitro culture where it is not pos-
sible to follow the progeny of T cell due to cell movement or cell cycle inhibitors, here, we used a 
platform that confined the cell in micro-groove (Figure 6.2A) (Trachsel et al., Submitted). Cells were 
encapsulated and restricted to move and grow along one axis, which prevented cells from inter-
changing their position with other cells. By selecting grooves containing one APC and one T cell, we 
first showed that the immunological synapse can be studied (Figure 6.2B) and then demonstrated 
using fluorescent immunostaining that protein expressions comparison could be achieved between 
different generations of cells or between sister cells (Figure 6.4). To promote T cell activation in our 
system, we used naive CD8+ OT1 TCR-transgenic T cells (OT1) that are specific for ovalbumin peptide 
(OVA), and, as APC, we selected OVA-transfected cell line, namely, EG7, which synthetizes and se-
cretes OVA212,213. EG7 cells are derived from the T-cell lymphoma EL-4. Professional APC such as 
dendritic cells (DCs) may not have been used to activate OT1 as DCs are very motile, adherent and, 
more importantly, much larger than T-cell. To encapsulate DCs, the groove width must have been 
increased to the extent that the T cell would not be constrained and might freely move in all direc-
tions, leading to ambiguous tracking.  
6.3.1 CD8+ T cell activation with EG7 
Previous studies have demonstrated that EG7 cells can directly present OVA to OT1, which in turn 
activate them in the presence of IL2212,214. Nevertheless, to establish it in our system, we co-cultured 
cells to assess whether OT1 can be efficiently activated by EG7 cells. Activation markers (i.e. CD69, 
CD27 and CD8) were up regulated after the co-culture (Figure 6.1C and Supplementary Figure S6.1) 
with a concomitant cell proliferation and cell size increase (indicated by dilution of CTV and FSC 
profile, Figure 6.1A-B). This indicated that OT1 were already activated after 24 h of co-culture209,215. 
The CD8 expression was proposed as an asymmetric marker that can help distinguish the effector 
(CD8 high) and memory (CD8 low) lineages after the first division is Linked to CD8 high cell. The 
expression of CD69, CD27 and CD44 should also be upregulated and that of CD62L downregulated. 
In contrast, the CD8 low cells are CD69, CD27, CD44 low and CD62L high206,208. We wondered if we 
could replicate this observation using our system (Figure 6.1D). In line with the above description, 
we observed that the CD8 high population exhibited more effector-like phenotype than CD8 low 
due to an up-regulation of CD69, CD27 and CD44. However, a notable exception was the presence 
of CD62L (Figure 6.1) on CD8 high cells, which is a marker of memory T cells, an observation that is 
different from that of Chang et al.’s and others208,216. One possible explanation for this result is that 
Chang et al. used another protocol that involves in vivo CD8+ T cell activation and not in vitro, like 
in our study. The differences of protein expressions between CD8 low and CD8 high were not seen 
on non-activated cells (Supplementary Figure S6.2), which confirmed that a difference in marker 
expression is induced upon EG7 mediated activation and not already present in freshly isolated na-
ive T cells. Overall, these results suggested that OT1 were activated by EG7 cells and that asymmetric 
divisions occurs; yet, the presence of CD62L on CD8 high cell also indicated that daughter cells after 
the first divisions are probably different in our approach than the ones of Chang et al.206 
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6.3.2 EG7 and OT1 culture on the micro groove platform 
EG7 and OT1 cells were seeded on the micro-groove platform and observed by time-lapse micros-
copy (Figure 6.2). In general, the OT1 cells, alone or in multiple numbers, had very low viability in 
the absence of EG7. A possible explanation for this is that in contrast to standard well culture where 
the cells are touching each other, the cells here are spatially separated and probably suffer from a 
lack of signals that induce apoptosis (Figure 6.2C(3)). Although cell death was decreased when OT1 
were in the presence of EG7, we still observed occasional cell death in these grooves (Figure 6.2C(1)-
(2)). To observe immunological synapse, we selected grooves that contained one single OT1 and  
Figure 6.1: In vitro activation of OT1 CD8+T cell by EG7 cells. (A) CellTrace violet dilution of OT1 cells on day 0, 1 and 2 post co-
culture with EG7. (B) Forward side scattering (FSC) profile of OT1 on day 0, 1, and 2 post co-culture with EG7. (C) Activation marker 
levels on day 0 (undivided cells),1 and 2. (D) Activated OT1 cells that divided one time were sub-fractioned in CD8 low and high 
populations and analyzed with CD62L, CD69, CD44 and CD27. Control is not activated in OT1 cells.  
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 EG7 cell (Figure 6.3A-B) where the OT1 gave rise to two daughter cells (ensuring that the OT1 cells 
were activated).  
We observed two modes of interaction between cells: a continuous (Figure 6.3A) and an intermit-
tent contact (Figure 6.3B). These modes were already defined by Dustin et al. who proposed to call 
them as “immunological synapse” (continuous mode) and “immunological kinapse” (intermittent 
mode)217. After the synapse, the T cell divided and increased in size, indicating that they were acti-
vated218.  
 
Figure 6.2: OT1 and EG7 cells co-culture in micro-groove array. (A) Micro-groove with OT1 and EG7 cells. Black arrows indicate
groove containing one single cell of each type. (B)  Representative example of groove filled with one EG7 (bigger cells in the red
circle) and one OT1 (smaller cells in the green circle) cells. (C) Representative fate of OT1 in the groove, (1) OT1 cell doing an 
immunological synapse with one EG7 and proliferating, (2) OT1 with one EG7 but dying, (3) single OT1 dying. OT1 cells are depicted 
in green in schemes and EG7 in red. Scale bar = 25um 
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6.3.3 Analysis of asymmetry between daughter cells 
To assess the asymmetric protein distribution between daughter cells upon T cell activation and 
division, we estimated the CD8 expression by antibody staining on live cells102 (Figure 6.4). We se-
lected CD8 as it is an established marker of asymmetric division for CD8+ T cell206. It is important to 
note that due to the massive cell death observed when OT1 and EG7 were directly placed on the 
tracking platform, here, we first co-cultured EG7 and OT1 in a standard cell culture plastic well plate 
overnight to provide better activation. We obtained 7 grooves through which we were able to track 
cells up to the second generations (Figure 6.4). We defined the first generation as pair daughter 
cells (PDCs) and the second generation as cousin cells. Cousin cells are, therefore, two pairs of sister 
cells (Figure 6.4B). We compared the CD8 distribution asymmetry of sister cells between these two 
generations and found that cousin cells exhibit significantly higher level of asymmetry than PDCs 
(Figure 6.5A). To assess if the CD8 expression level of the PDCs can influence the CD8 distribution 
asymmetry of cousin cells, we classified the cousin cells according to the CD8 expression of their 
mother cells (i.e., first generation cells) (Figure 6.5B). However, due to a large variability, we did not 
find the expression to be significantly different (Figure 6.5B). Finally, to see whether the first gener-
ation daughter cell that has a higher expression of CD8 produces more asymmetric second genera-
tion daughters, we compared the asymmetries of cousin cell pairs based on the CD8 expression of 
PDCs (first generation daughters) (Figure 6.5C). We found that the CD8 low first generation daughter 
cell produces cousin cells that have a significantly more asymmetric distribution of CD8 when com-
pared to their respective CD8 high sister. Overall, our results are intriguing as they provide new 
information on T cell asymmetry. Firstly, Verbist et al. showed through FACS analysis that the two 
populations of CD8 high and CD8 low found after the first divisions dissipated after subsequent di-
visions206,208, but the sister cell CD8’s protein asymmetric distribution was never assessed. Here, we 
found that the second generation of cells exhibited more asymmetric CD8 distribution than the first 
generation. Another contrasting observation to the current dogma is how the daughter cell with 
low CD8 expression produces more asymmetric cell division208. Although still preliminary, we be-
lieve that these contradicting observations could arise from the use of non-standard plate culture 
Figure 6.3: Representative images showing two different types of interaction between OT1 and EG7. (A) immunological synapse and
(B) immunological kinapse (ON/OFF interaction) as defined by Dustin et al.217. Black arrows show the images where interactions 
occurred. 
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conditions. The optimization of precise culture conditions in cell grooves will be needed in the fu-
ture. Further analysis with more cell numbers would be needed to draw reliable conclusions from 
this methodology. However, to our knowledge, this is the first attempt to track T cell fate over sev-
eral generations using in vitro.  
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Figure 6.4: CD8 protein expression in OT1 cell lineages. (A) OT1 cells were co-cultured with EG7 for 24 h and placed on the micro-
groove array platform. Single OT1 lineage were tracked (images on the left) and CD8 protein expression was measured for the 
mother, PDCs and cousin cells (Graphs). (B) The scheme demonstrates how sister cell pairs are defined. 
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6.4 Conclusion 
With limited technical expertise available in the field to study immunological synapse and T cell 
progeny at the single cell level in vitro, we attempted to establish a method that is aimed at enabling 
the analysis of cell interaction between a CD8+ T cell and an APC combined with a lineage tracking. 
We successfully showed the occurrence of two types of interactions between OT1 and EG7—
namely, the immunological synapse and kinapse. Furthermore, we demonstrated that in addition 
to reliable tracking, protein expression analysis could be performed with our method for up to two 
divisions. However, the viability of OT1 EG7 cocultures was surprisingly low in our platforms; 
thereby restricting high throughput analysis. One way of obtaining better survival rates could be to 
seed more EG7 cells ensuring that each groove contains multiple EG7 cells. We think that our 
method can be further optimized to yield reliable results on T cell fate tracking in vitro. Thus, alt-
hough preliminary, our method is the first step towards a high-throughput analysis of T cells and 
their lineages.  
Figure 6.5: CD8 asymmetry in PDC and cousin cell pairs. (A) A comparison of CD8 asymmetry between PDC (green) and cousin pairs
(blue). Statistical analysis is performed by Student t-test: *p<0.05 (B) Comparison of cousin pairs derived from a daughter with high 
CD8 expression (blue) or low CD8 expression (red).(A)-(B) Asymmetry in sister cells is calculated as follows |?? ? ??|/(?? + ??), 
where ?? ??? ?? represent the sister cell values. (C) The difference of asymmetry of cousin pairs derived from a CD8 high or CD8
low mother. ???8 ???? =  |?? ? ??|, where ?? ??? ?? represent the sister cell values derived from the CD8 high daughter cells
and, similarly,???8 ??? =  |?? ? ??|, where ?? ??? ?? represent the sister cell values derived from the CD8 low daughter cells. 
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Figure S 6.2: Non-activated OT1 cells staining shows no difference between CD8high or CD8low cells. 
Figure S 6.1: Augmentation of CD8 expression after OT1 activation by EG7. 
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 General discussion and outlook 
For a better treatment of blood disorders, the number of HSCs must be expanded in vitro. However, 
the culture of HSCs is currently facing major problems due to the rapid loss of their functionality 
brought about by cell differentiation after initial divisions. This limits the usage of HSCs in regener-
ative medicine. In addition, freshly isolated HSCs once in culture either progressively lose their initial 
markers or become unreliable in the identification of functional HSCs37. This PhD thesis presents 
new methodologies using micro-technologies as a means to improve the analysis of HSCs in vitro.  
7.1 Technological development (Chapters 2 and 3) 
Current techniques only permit lineage tracking of extremely robust cells with the additional pre-
requisite of starting with a large number of cells (i.e. 20,000–50,000) 82,89,105. Moreover, these plat-
forms do not necessarily allow immunofluorescence staining on cell progenies. This is a major limi-
tation to the detection of markers that could potentially allow the identification of distinct cell line-
ages. 
In the first section of the thesis, a platform was developed to enable the high-throughput lineage 
tracking of primitive HSCs (chapter 2) with the possibility of conducting downstream analysis like 
immunostaining. The key difficulties to be solved during this task was the adoption of a methodol-
ogy for (1) reliable and gentle single cell capture, (2) unambiguous cell lineage tracking and (3) im-
munofluorescence staining without the risk of flushing/mixing the cells. To achieve our aims, we 
designed a hybrid platform composed of two different hydrogels that can be bonded together upon 
cell seeding. The bottom layer was made of poly (2-hydroxyethyl methacrylate)-trimethylolpropane 
trimethacrylate copolymer (pHEMA-TMPTMA) and the top layer was made in a self-assembling 
poly(ethylene glycol) (PEG). The combination of these two different hydrogels permitted the encap-
sulation of single cells into grooves in a very gentle. Due to the porousness of the PEG-lid, nutrients 
reached the cells passively. For the same reason, we were able to perform immunostaining in order 
to quantify protein expression at the single cell level in different lineages.  
The viability of HSCs cultured on the platform was the same as a conventional cell culture plate. We 
were therefore able to successfully culture HSCs, overcoming a major challenge that has plagued 
other state-of-the art devices. In contrast to previous approaches that require extensive tubings, 
micro-pumps and other expensive instruments to achieve cell progeny tracking, the platform pre-
sented here is not based on fluidics and is user friendly. It relies only on gravity to trap single cells 
inside closable microgrooves. The platform can be modified to track the progeny of other cell types, 
and the length of the grooves can be readily extended for longer-term cell tracking. Finally, we 
showed the proof-of-concept possibility of modification of the cell-contacting surface of the hydro-
gel with the protein molecules. Such surface modifications can be used to influence the fate of cul-
tured cells via numerous bioactive cues. To our knowledge, this platform is the first successful at-
tempt that allows the culture of the most primitive HSCs combined with the aforementioned re-
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quirements. To cope with the amount of data generated during time-lapse microscopy, we imple-
mented a tracking algorithm designed for the detection and tracking of HSCs (Chapter 2). Our algo-
rithm provided robust and efficient cell detection, while the average error in cell tracking accuracy 
was only 0.03 per 100 images. We demonstrated the usability of this tool for practical biological 
applications by analyzing the behavior of HSCs, exposed to three different drugs.  
7.1.1 Suggestion for the enhancement of the current platform 
The platform is closed with a PEG-lid after cell seeding. Although the platform closing is efficient, 
this procedure can be further optimized by implementing a more automatic closure protocol (i.e. 
deposition of the lid on the groove) that is not user-dependent. This procedure demands practice 
before being optimal. By the human hand, it is not possible to control the exact pressure that one 
exerts on the lid when closing the platform resulting in excessive pressure and in an increased pos-
sibility of cell-death. A simple tool made of a mechanical arm that would carry the lid and gently 
deposit it on the platform, for example, would permit a more reproducible closure. The aforemen-
tioned tool could address this limitation by applying constant pressure and in a more homogenous 
manner over the lid.  
Lecault et al. developed a platform for in vitro HSCs’ culture combined with a system that permitted 
the automated medium exchange (platform described in the introduction of this thesis). This plat-
form permitted the identification of the time-window where HSCs are responsive to steel factor79. 
Change of media (i.e. media perfusion) is therefore a technical improvement that could be beneficial 
to the current groove-platform described in this thesis. This technology will offer another level of 
analysis to identify when cells are more responsive to cytokines and if combined with live-im-
munostaining102, we could determine how cytokines are linked to the (dis)appearance of hemato-
poietic cell surface markers (e.g. CD34, CD48, CD150, Tie2, ckit, sca114,15,189) or to metabolism. 
An extremely useful read-out that could be targeted with this platform would be to assess the long-
term potency of cultured HSCs by transplanting them into an irradiated recipient. To achieve this, 
single cells should be harvested from the platform through micromanipulation using microcapillar-
ies. This approach is known to yield a low throughput but offers the precision required for single cell 
transplantations. Alternatively, this method could be used to study the gene expression of entire 
lineage of HSCs. Every time a cell divides, one daughter is harvested and its RNA would be se-
quenced. Difference of gene expression could be therefore quantified during HSCs’ in vitro culture. 
An issue of practical interest is that the lid could potentially clog the needle of the microcapillary 
since it is made of a soft hydrogel. Hence, the operation of single cell micromanipulation should be 
first optimized.  
7.2 Biological experiments (Chapters 4 to 6) 
The aim of the platform (described in chapter 2) was to allow the tracking and analysis of HSC proge-
nies. We demonstrated this concept by analyzing the protein expression for all cells generated dur-
ing culture from freshly isolated murine HSCs. To observe distinct lineages arising from an asymmet-
ric division (AD), we calculated the difference of protein expression between daughter cells of the 
first generation and combined this information with the temporally asymmetric divisions (i.e. asyn-
chronous divisions). Since asynchronous division is a phenomenon associated with asymmetric cell 
divisions129, we were able to locate proteins that are asymmetrically distributed during asymmetric 
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division. This strategy is the first step towards the finding of reliable markers defining HSCs cell lin-
eages in vitro.  
In the following chapters of this thesis, we used the platform to study asymmetric protein (or orga-
nelles) distribution between sister cells. Asymmetric division is a process that is well-established for 
stem cells where one daughter proliferates and differentiates whereas the other daughter remains 
identical to the mother (maintaining the stem cell pool)203. Consequently, AD is the most relevant 
cell fate choice under homeostasis 170.  
7.2.1 Chapter 4 “Monitoring of mitochondrial mass of HSCs in culture” 
In chapter 4, we used a genetically modified mouse line that expresses enhanced green fluorescent 
(GFP) protein in mitochondria to measure mitochondrial mass and its distribution in daughter cells. 
Our experiments revealed the existence of a specific distribution mechanism that segregates mito-
chondria preferentially to one of the daughter cells during an asymmetric division. These results 
further support the contention that HSC fate is tethered to the mitochondria161.  
Using the same assay, an investigation can be carried out to distinguish whether mitochondrial mass 
distribution during asymmetric division is also linked to the difference in metabolic activity of these 
mitochondria. This experiment is performed in a serum-free medium supplemented of two cyto-
kines (SCF and Flt3l, basal medium). Supplementation of IL3 and IL6 to the basal medium would lead 
to a decrease of asynchronous divisions and rapid proliferation associated to lineage commitment 
of HSCs in vitro42,129. Therefore, it would be interesting to see how mitochondrial mass is distributed 
during these symmetric commitment divisions.  
7.2.2 Chapter 5 “Analysis of asymmetric markers in the first generation of cells derived 
from murine HSCs” 
In chapter 5, we report a strategy to analyze the asymmetric expression of genes and proteins during 
AD. We used IFNa to promote the exit of HSCs out of their dormancy in their in vivo niche174. 
Thereby, dividing HSCs were “pre-instructed” in their in vivo environment. This is a major advantage 
provided by our method as HSCs in the absence of the right cues from the in vivo niche rapidly 
differentiate in vitro. This experiment provided numerous insights for HSCs phenotypic characteri-
zation in vitro. Our single cell gene expression analysis in paired daughter cells (PDCs) allowed the 
identification of an asymmetric gene set. Among them were some genes that have been described 
in the literature to be important for HSC identification such as CD15013, Tie2197 and JAM350,192. In-
terestingly, Tie2 (receptor of Ang1) has been previously used as an asymmetric marker51. We also 
identified some metabolic genes such as Glucose transporter 1 (Glut1), Hexokinase 2 (HK2) and Ac-
onitase 1 (Aco1) in highly asymmetric PDCs. We further explored the maintenance of this asymmetry 
at the level of protein expression. Protein analysis revealed significantly higher asymmetric protein 
expression in three candidates, namely Glut1, JAM3 and HK2, suggesting maintenance of asym-
metry post-translation.  
Our functional analysis using CFUs revealed Glut low JAM3 high to be the most primitive subset in 
culture. This is in line with previous reports showing lower Glut1175 and high JAM350 in functional 
HSCs. Further in vivo functional assays should be undertaken to confirm that asymmetry at the pro-
tein level corresponds with the asymmetric fate of daughter cells. We believed that this experiment 
could be used to further characterize daughter cells during an asymmetric division in the future. 
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7.2.3 Chapter 6 “Fate analysis of CD8+ T cell at the single cell level” 
A host organism mounts a well-orchestrated immune response upon microbial infection. Cytotoxic 
T lymphocytes (CD8+ T cells) are an important arm of this immune response and generate various 
subsets to protect the organism against the pathogen. It was recently shown that these different T 
cell subsets, namely the effector and memory cells, emerge from a common CD8+ T cell ancestor. 
In chapter 6, we attempted to establish a new methodology to observe and analyze T cell lineages 
at the single cell level. The primary aim was to observe the process of T cell activation and prolifer-
ation with its activation by an antigen presenting cells. We successfully observed two types of inter-
actions between a T cell and an antigen presenting cells—the immunological synapse and kinapse. 
Furthermore, we also demonstrated that in addition to reliable tracking, protein expression analysis 
could be performed with our method for up to two divisions. 
In the frame of this thesis, this experiment provided the proof that a co-culture can be achieved on 
the tracking platform and in the frame of a T cell. Our analysis further supports that the first initial 
division of T cells are asymmetric. In this last experiment, a few points can be optimized to yield 
more reproducible results. (1) The culture method should be optimized to provide a better cell via-
bility on the platform. (2) Analysis of asymmetric protein expression after the second division should 
be carried out to investigate whether asymmetric division still occurs in subsequent division. (3) 
Other markers apart from CD8 should be used to more precisely characterize the difference be-
tween daughter cells. To achieve this aim we suggest starting with genes that were observed to be 
essential for asymmetric division of T cell, such as the Atypical protein kinase C (aPKC), Par3, Scrib 
and DIgF208,209,211,219. Moreover, a metabolic profiling of daughter T cells would surely provide inter-
esting insights. In contrast to stem cells and in particular HSCs, where quiescent cells are marked by 
low mitochondrial mass50,220, it was proposed that dormant memory T cells exhibit elevated mass 
of mitochondria while highly proliferating effector T exhibit low mitochondrial mass221. 
7.3 Future biological application  
The number of experiments conducted to understand mechanisms underlying stem cell fate deci-
sions using the platform developed in this thesis is infinite. The following sections include recom-
mendations for further experiments to help develop a better understanding of cell fate decisions.  
7.3.1 Mouse and human HSCs 
For future studies with our platform, an obvious experiment to undertake would be to combine 
lineage tracking of HSCs when cultured in the presence of other cell types—typically, cells from the 
hematopoietic niche. In vivo observation of niche-cell interaction with HSCs followed by HSCs line-
age tracking is currently not possible to implement19. However, in vitro co-culture of HSCs with niche 
cells can be undertaken with our platform to decipher mechanisms influencing HSCs’ fate after cell-
cell interaction. Interestingly, bulk co-cultures in conventional plate have been performed with os-
teoblast and mesenchymal stem cells and already demonstrated exciting results for ex-vivo HSCs’ 
expansion222–225. Co-culture combined to further assays (i.e. immunostaining, qPCR), would permit 
a better characterization of key proteins involved in the niche and in the fate decision of HSCs. In 
chapter 5 of this thesis, we pointed out that the cell-cell protein JAM3 is expressed in the most 
primitive cells in culture191 and can be used to identify HSCs in vitro. In the in vivo niche, JAM3 (ex-
pressed by HSCs) interacts with JAMB on bone marrow stromal cells191. Therefore, it would be ex-
tremely interesting to culture HSCs with genetically modified bone marrow stromal cells expressing 
less/more JAMB and to observe how this molecule changes HSC fates in vitro.  
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In addition to the co-culture experiment, relevant protein candidates of the extra-cellular matrix of 
the niche could be tethered in the grooves, as we have shown in chapter 2. Therefore, the next 
generation of the groove platform should facilitate the exposure of HSCs to “artificial niches” to find 
how protein in the niche can modulate HSC fate choices120,129. Such experiments were already per-
formed but never in the context of entire lineages120. To achieve this, the protocol that was devel-
oped in chapter 2 should be adapted so that the platform can be still closable even in the presence 
of molecules on the groove-surface.  
During this thesis, we primarily focused on the characterization of murine HSCs but we still do not 
know whether these results could be applied to human HSCs. A typical example of the difference 
between murine and human HSCs is the presence or absence of CD34 respectively on human and 
murine HSCs190,226. We think that the observation of human HSCs on the platform could be ex-
tremely interesting and straightforward with direct impact at the clinical level.  
7.3.2 Suggestion of studies with other stem or tumor cells  
Although the focal point of this thesis was the study of HSCs, the platform is not restricted to these 
types of cells. For example, the approach that was described in chapter 4 can be expanded to assess 
the pluripotency in progenies of other stem cells by using fluorescent reporter genes such as Lgr5 
for intestinal stem cells227, Nanog for embryonic stem cells228 or induced pluripotent stem cells (iPS 
cells)229. Moreover, the progeny of stem cells can be stained on the platform to test the presence 
of other stem or lineage commitment markers. Similarly, the exact mechanisms of OCT4, SOX2, 
KLF4, c-MYC occurring during the reprogramming of somatic cells into iPS cells could be observed 
on the platform. Meanwhile, the cooperation of factors to reshape the epigenome and gene expres-
sion profile of somatic cells could be elucidated 230.  
Tumor cells are highly heteregenous231 but current therapies treat cancer as a homogeneous dis-
ease which often leads to an incomplete healing. Defining the pathways through which tumors pro-
gress in the presence of drugs could lead to a better characterization of these cells and would ulti-
mately allow us to find new ways to treat cancer232. However, so far cancer cells are mostly studied 
by micro-array and flow cytometry technologies where the genealogical relationships of cells are 
lost. Therefore, we are still missing the exact mechanism underlying drug resistance of cancer cells. 
The platform presented in this thesis could address these limitations and permit the characteriza-
tion of cancer development in vitro. 
However, it should be noted that the bottom layer of the platform should be modified if other cell 
types are used. First, the width of the grooves must be scaled to fit the dimension of each cell type. 
The length of the grooves can be also modified depending on the number of cells of the progenies. 
For the analysis of adherent cells, moreover, a method to coat the platform to prevent cells’ adhe-
sion has to be investigated. To achieve this, I propose the usage of a nonfouling polyethylene glycol-
like film. Without this treatment, cells might escape from the groove even in the presence of the lid 
and might be difficult to track unambiguously.  
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